ATTACHMENT A- Test Menu 12.18.24.xlsx
XLSX spreadsheet 104 KB Posted
- Attached to
- VISN 1 Primary Reference Laboratory Testing
- Solicitation number
- 36C24124Q0194
About this file
This is a test menu spreadsheet related to a VA sources sought notice for reference laboratory testing services, phlebotomy services, and courier services for all VISN1 sites. The spreadsheet lists approximately 1,000 different laboratory tests with their estimated yearly quantities, including blood tests, cultures, immunology panels, genetic testing, drug screening, and various other clinical laboratory analyses.
The related sources sought notice (36C24124Q0194) is seeking responses from qualified laboratories by January 3, 2025 at 4:00 PM EST. The requirement falls under NAICS code 621511 (Medical Laboratories) with a size standard of $41.5 million. Respondents must demonstrate they are fully licensed/accredited, have at least 3 years of laboratory services experience, employ a certified Pathologist or Bio-analyst as Laboratory Director, maintain appropriate CLIA certifications, and can provide draw stations operational on day one. The VA is conducting this market research to determine if there are sufficient socioeconomic small businesses capable of performing the work before determining the acquisition approach.
View the file
Other files
Show all 12
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Attachement A
VENDOR ENTER COLUMNS IN BLUE
| Test Name - Current Vendor Quest | CLIA CPT Code(s) - Vendor | CLIA CPT Code(s) - Subcontractor | VA's Estimated Yearly Qty | |
| 14-3-3 PROTEIN, CSF | 5 | |||
| 17-HYDROXYCORTICOSTEROIDS | 5 | |||
| 17-HYDROXYPREGNENELONE | 5 | |||
| 17-HYDROXYPROGEST LCMSMS | 62 | |||
| 17-KETOSTEROIDS (URINE) | 5 | |||
| 2,3-DINOR 11B-PROS | 5 | |||
| 21-HYDROXYLASE AB | 4 | |||
| 24HR URINE KAPPA LAMBDA | 2 | |||
| 4K PROSTATE SCORE (SERUM) | 38 | |||
| 5 HIAA | 10 | |||
| 5 NUCLEOTIDASE | 28 | |||
| 5-HIAA W/CREATININE 24 HR | 6 | |||
| 5HIAA(SEROTONIN) | 46 | |||
| 5-HIAA, PLASMA | 41 | |||
| 5-HYDROXYINDOLEACETIC ACI | 5 | |||
| 6-ACETYLMORPHINE | 5 | |||
| A FENT, U | 5 | |||
| A. ALTERNATA (M6) | 5 | |||
| A. FUMIGATUS (M3) | 10 | |||
| A. PHAGOCYTOPHILUM/E. CHA | 336 | |||
| A-1-ANTITRYP QT & PHENO | 26 | |||
| AAT, IHC W/O INTERP | 5 | |||
| AB SCR RFX ID/TITER | 5 | |||
| ABL KINASE DOMAIN | 2 | |||
| ACANTHAMOEBA/NAEGLERIA | 5 | |||
| ACCUTYPE(R) IL28B | 2 | |||
| ACCUTYPE(TM)CP,CLOPIDOGRE | 17 | |||
| ACE, CSF | 11 | |||
| ACETAMINOPHEN | 5 | |||
| ACETONE | 1 | |||
| ACETYL FENTANYL U | 79 | |||
| ACETYLCHOLINE REC MOD AB | 5 | |||
| ACETYLCHOLINE RECEPTOR | 359 | |||
| ACETYLCHOLINE RECEPTOR BL | 90 | |||
| ACID-FAST BACILLI ID, | 5 | |||
| ACTH STIMULATION,3 SPEC. | 1 | |||
| ACTH, PLASMA | 647 | |||
| ACTIN ANTIBODY (IGG) | 720 | |||
| ACTIVATED PROTEIN C RESIS | 34 | |||
| ACUTE MYELOID LEUKEMIA | 5 | |||
| ACYLCARNITINE PLASMA | 5 | |||
| ADALIMUMAB | 2 | |||
| ADALIMUMAB ADA FOR IBD | 6 | |||
| ADALIMUMAB ADA FOR RHEUM | 5 | |||
| ADALIMUMAB LEVEL/ADA, IBD | 28 | |||
| ADALIMUMAB LEVEL/ADA,RHEU | 35 | |||
| ADAMTS13 ACTIVITY W/REFLE | 18 | |||
| ADAMTS13 INHIBITOR | 2 | |||
| ADENOMATOUS POLYPOSIS PANEL | 5 | |||
| ADENOSINE DEAMINASE, CSF | 1 | |||
| ADENOSINE DEAMINASE, PERI | 5 | |||
| ADENOSINE DEAMINASE, PLEU | 13 | |||
| ADENOVIRUS ANTIBODY GROUP | 5 | |||
| ADENOVIRUS DNA, QUAL RT | 5 | |||
| ADENOVIRUS DNA, QUANT. | 5 | |||
| ADMARK APOE GENOTYPE | 86 | |||
| ADMARK EARLY ONSET ALZHEIMER | 5 | |||
| ADMARK PROFILE | 7 | |||
| ADmark(R)Phospho-Tau/Total-Tau/A Beta42,Interp,CSF | 5 | |||
| ADRENAL AB SCREEN W/ RFLX | 11 | |||
| AFB BROAD-RANGE PCR | 5 | |||
| AFB CULT & SMEAR PROG | 5 | |||
| AFB CULT BLD PROG ID&SENS | 5 | |||
| AFB CULT:PROG PROB,ID,SEN | 5 | |||
| AFB ID, SEQ.&STAIN,PARAFF | 2 | |||
| AFP, IHC W/INTERP | 5 | |||
| AFP, IHC W/O INTERP | 5 | |||
| AFP,TUMOR (CHIRON) | 5 | |||
| AGA ACTIVITY, SERUM | 5 | |||
| ALBUMIN | 5 | |||
| ALBUMIN RNA ISH | 5 | |||
| ALBUMIN, CSF | 4 | |||
| ALBUMIN, SYNOVIAL FLUID | 1 | |||
| ALBUMIN,PERICARDIAL FLUID | 5 | |||
| ALC METAB U | 5 | |||
| ALCOHOL METAB, QN, U | 5 | |||
| ALCOHOL, ISOPROPYL | 5 | |||
| ALCOHOL, METHYL (B) | 2 | |||
| ALCOHOL,METHYL | 4 | |||
| ALDOLASE | 653 | |||
| ALDOST/CORTISOL, 2 SITES | 4 | |||
| ALDOSTERONE, LC/MS | 516 | |||
| ALDOSTERONE, URINE | 53 | |||
| ALDOSTERONE/CORTISOL | 5 | |||
| ALDOSTERONE/PLASMA RENIN | 539 | |||
| ALK 1, IHC W/O INTERP | 5 | |||
| ALKALINE PHOSPHATASE | 82 | |||
| ALKALINE PHOSPHATASE ISO | 168 | |||
| ALLERGEN - RICE IGG | 1 | |||
| ALLERGEN-CACAO (CHOCOLATE | 1 | |||
| ALLERGY ANIMAL PANEL #6 | 5 | |||
| ALLERGY FOOD PANEL | 5 | |||
| ALLERGY NORTHEAST REGIONA | 132 | |||
| ALLERGY NUT PANEL #2 | 43 | |||
| ALLERGY PANEL #13 | 68 | |||
| ALLERGY PANEL #18 | 88 | |||
| ALLERGY PANEL #19 | 80 | |||
| ALLERGY PNL, ANIMAL GROUP | 10 | |||
| ALLERGY SHELLFISH PANEL 1 | 59 | |||
| ALLERGY STINGING INSECT | 5 | |||
| ALLERGY TREE PANEL # 6 | 641 | |||
| ALLERGY WEED PANEL #6 | 642 | |||
| ALLERGY-GRASS PROFILE + | 638 | |||
| ALMOND (F20) IGE | 46 | |||
| ALPHA 1-ANTITRYPSIN 24HR | 1 | |||
| ALPHA 1-ANTITRYPSIN, IHC W/O INTERPRETATION | 5 | |||
| ALPHA 1-ANTITRYPSIN, RND | 11 | |||
| ALPHA 2-ANTIPLASMIN | 6 | |||
| ALPHA 3 AB | 1 | |||
| ALPHA GAL IGE | 36 | |||
| ALPHA SUBUNIT | 30 | |||
| ALPHA-1 ANTITRYPSIN QNT. | 5 | |||
| ALPHA-1-ANTITRYPSIN (AAT) | 31 | |||
| ALPHA-1-ANTITRYPSIN PHENO | 85 | |||
| ALPHA-1-ANTITRYPSIN,FECES | 5 | |||
| ALPHA-FETOPROTEIN (AFP) | 5 | |||
| ALPHA-FETOPROTEIN, IHC W/O INTERP | 5 | |||
| ALPHA-FETOPROTEIN,CSF | 5 | |||
| ALPHA-GALACTOSIDASE, SER | 7 | |||
| ALPHA-GALACTOSIDASE,LEUK | 6 | |||
| ALPHA-GLOBIN COMMON | 11 | |||
| ALPHA-GLOBIN GENE | 11 | |||
| ALPRAZOLAM (XANAX) | 1 | |||
| ALPRAZOLAM/MET CONF BLD | 5 | |||
| ALS,DEMENTIA & ALZHEIMER | 5 | |||
| ALT | 1 | |||
| ALUMINUM, SERUM | 48 | |||
| ALUMINUM, WHOLE BLOOD | 5 | |||
| AMERICAN CHEESE,IGE | 5 | |||
| AMH, FEMALE | 52 | |||
| AMH, MALE | 4 | |||
| AMIKACIN, PEAK | 4 | |||
| AMIKACIN, TROUGH | 2 | |||
| AMINO ACID ANALYSIS, UR | 2 | |||
| AMINO ACID ANALYSIS,PLAS | 1 | |||
| AMIODARONE | 20 | |||
| AMITRIPTYLINE | 37 | |||
| AMMONIA, (P) | 5 | |||
| AMOXICILLIN (C6) IGE | 6 | |||
| AMPH CONF GCMS URINE | 5 | |||
| AMPHETAMINE BY GCMS, SERU | 5 | |||
| AMPHETAMINE, CONF GCMS UR | 19 | |||
| AMPHETAMINE,CONF,GC/MS SE | 1 | |||
| AMPHETAMINES QN U | 5 | |||
| AMPHIPHYSIN AB TEST | 5 | |||
| AMPHOTERICIN B-ANTIFUNGAL | 5 | |||
| AMYLASE | 5 | |||
| AMYLASE BF | 5 | |||
| AMYLASE ISOENZYMES | 1 | |||
| AMYLASE, PANCREATIC CYST | 5 | |||
| AMYLASE, RAND UR W/CREAT | 2 | |||
| AMYLOID A, IHC W/O INTERP | 2 | |||
| AMYLOID A, IHC W/O INTERP | 5 | |||
| AMYLOID PROTEIN ID LC MS/MS | 5 | |||
| AMYLOID RELATED DISORDER | 5 | |||
| AMYLOIDOSIS EVAL. (TTR) | 5 | |||
| ANA IFA, WITH REFLEX TO | 692 | |||
| ANA W/RFX | 5 | |||
| ANA, TITER AND PATTERN | 262 | |||
| ANABOLIC STEROIDS SCRN, U | 242 | |||
| ANACHOICE(R) SPEC CASCAD | 5 | |||
| ANACHOICE(TM)SCREEN W/R | 5 | |||
| ANAEROBE E-TEST PROFILE | 1 | |||
| ANAEROBIC ID AND E TEST | 11 | |||
| ANAPLASMA PHAGOCYTOPHILUM | 337 | |||
| ANAPLASTIC LYMPHOMA KINAS 1 IHC W/O INTERP | 5 | |||
| ANCA SCREEN W/ REFLEX TO | 470 | |||
| ANCA SCRN W/MPO AND PR3 | 229 | |||
| ANCHOVY(ENGRAULIS ENCRASI | 1 | |||
| ANDRO IHC W/O INTERP | 1 | |||
| ANDROGEN RECEPTOR,IHC W/I | 1 | |||
| ANDROGEN RECEPTOR,IHC W/O | 5 | |||
| ANDROSTENEDIONE,LC/MS/MS | 11 | |||
| ANGIOTENSIN CONV ENZ | 457 | |||
| ANNEXIN-1, IHC W/O INTERP | 1 | |||
| ANTI PM/SCL-100 AB | 4 | |||
| ANTIBIOTIC SENSI TESTING | 11 | |||
| ANTIBIOTIC SENSITIVITY | 1 | |||
| ANTI-DSDNA AB, EIA | 5 | |||
| ANTIFUNGAL MIC-8 | 5 | |||
| ANTI-GIARDIA LAMBLIA AB PANL | 5 | |||
| ANTI-HMGCR AUTOANTIBODIES | 5 | |||
| ANTI-IBM ANTIBODY | 5 | |||
| ANTI-IGA | 5 | |||
| ANTI-ISLET CELL ANTIBODIE | 131 | |||
| ANTI-MDA-5 AB (CADM-140)(RDL) | 5 | |||
| ANTIMICROBIAL SUSC,AFB, | 5 | |||
| ANTIMICROBIAL SUSC. NOCAR | 5 | |||
| ANTIMICROBIAL SUSCEPT | 5 | |||
| ANTI-MULLERIAN HORMONE | 5 | |||
| ANTI-NUCLEAR AB (FANA), B | 1 | |||
| ANTIPHOSPHOLIPID SYNDROME | 60 | |||
| ANTI-PM/SCL ANTIBODY (EIA | 5 | |||
| ANTIPSYCHOTIC(S)CONFIRM | 5 | |||
| ANTIPSYCHOTICS, S | 5 | |||
| ANTI-STRIATED MUSCLE AB T | 1 | |||
| ANTITHROMBIN III | 98 | |||
| ANTITHROMBIN III ANTIGEN | 40 | |||
| ANTI-THYROGLOBULIN ANTIBO | 350 | |||
| Anti-TIF-1gamma Ab (RDL) | 5 | |||
| APC GENE DEL/DUPLI | 5 | |||
| APC GENE SEQUENCING | 5 | |||
| APIXABAN | 4 | |||
| APOE ISOFORM, PLASMA | 10 | |||
| APOLIPOPROTEIN A 1 | 5 | |||
| APOLIPOPROTEIN B | 70 | |||
| APOLIPOPROTEIN PROFILE | 56 | |||
| APPLE (F49) IGE | 16 | |||
| APRICOT (F237) IGE | 4 | |||
| APTT BLEEDING EVAL. | 5 | |||
| AQP4 (NMO IGG) | 4 | |||
| AQUAPORIN 4 AB, CBA | 4 | |||
| AQUAPORIN-4 AB (IGG),CBA | 5 | |||
| ARBOVIRUS AB PANEL,IFA SE | 2 | |||
| ARBOVIRUS ANTIBODY PANEL | 1 | |||
| ARGININE VASOPRESSIN | 5 | |||
| ARGINSE, IHC W/INTER | 5 | |||
| ARIPIPRAZOLE, QUANT | 40 | |||
| ARSENIC FRACTIONATION, UR | 5 | |||
| ARSENIC SPEC, 24 HOUR, U | 8 | |||
| ARSENIC, 24 HR URINE W/O | 7 | |||
| ARSENIC, BLOOD | 28 | |||
| ARSENIC, HAIR | 5 | |||
| ARSENIC, RANDOM URINE | 2 | |||
| ARSENIC, SPEC, RAND | 1 | |||
| ASCARIS (P1) IGE | 5 | |||
| ASCARIS IGG | 5 | |||
| ASCORBIC ACID | 5 | |||
| ASH FIBROSURE | 5 | |||
| ASHKENAZI JEWISH PNL (11) | 5 | |||
| ASPERGILLUS AB PNL CF ID | 1 | |||
| ASPERGILLUS AG, EIA, BAL | 20 | |||
| ASPERGILLUS ANTIBODIES, I | 85 | |||
| ASPERGILLUS ANTIBODY SCR | 4 | |||
| ASPERGILLUS ANTIGEN | 226 | |||
| ASPERGILLUS DNA, QUAL RT | 6 | |||
| ASPERGILLUS FUMIGATUS DNAby PCR | 5 | |||
| AST | 1 | |||
| Ataxia, Comprehensive Evaluation | 5 | |||
| ATYPICAL P-ANCA TITER | 25 | |||
| Autoinflammatory and Autoimmunity Syndromes Panel | 5 | |||
| AVOCADO (F96) IGE | 6 | |||
| B. HENSELAE IGG TITER | 6 | |||
| B. HENSELAE IGM TITER | 5 | |||
| B. QUINTANA IGG TITER | 2 | |||
| B. QUINTANA IGM TITER | 5 | |||
| B.HENSELAE IGG W/RFL | 5 | |||
| B.MIYAMOTOI AB | 5 | |||
| B.MIYAMOTOI PCR,MISC | 1 | |||
| B72.3, IHC W/INTERP | 5 | |||
| B72.3, IHC W/O INTERP | 5 | |||
| BABESIA MICROTI DNA RT | 5 | |||
| BABESIA MICROTI IGG,IGM | 372 | |||
| BACLOFEN (LIORESAL) | 2 | |||
| BACTERIAL 16S RDNA | 5 | |||
| Bacterial DNA Detection by PCR | 5 | |||
| BACTERIAL ID AND SUSCEPT. | 17 | |||
| BACTERIAL IDENTIFICATION | 5 | |||
| BACTERIAL VAGINOSIS/VAGIN | 2 | |||
| BANANA (F92) IGE | 10 | |||
| BARBITURATES QN U | 5 | |||
| BARBITURATES, CONFIRM SER | 5 | |||
| BARLEY (F6) IGE | 5 | |||
| BARTONELLA DNA, REAL-TIME | 6 | |||
| BARTONELLA HENSELAE (IGG | 24 | |||
| BARTONELLA SPECIES AB | 127 | |||
| BASEMENT MEMBRANE ZONE AB | 5 | |||
| BASIC METAB PNL | 8 | |||
| BASIC METAB PNL W/O CA | 2 | |||
| BASIL (RF269) IGE** | 5 | |||
| BASS BLACK IGE | 5 | |||
| B-CELL CLONALITY PANEL | 1 | |||
| B-CELL RECEPTOR IGH GENE | 1 | |||
| B-CELL RECEPTOR IGK GENE | 5 | |||
| BCL-2, IHC W/O INTERP | 82 | |||
| BCL-2/JH T(14 | 4 | |||
| BCL-6, IHC W/O INTERP | 6 | |||
| BCR-ABL 35 NT INSERTION | 5 | |||
| Beckwith-Wiedemann Syndrome/Russell-Silver Syndrom | 5 | |||
| BEEF (F27) IGE | 7 | |||
| BEET, IGE | 1 | |||
| BENCE JONES PROTEIN PNL | 5 | |||
| BENCE JONES PROTEIN, QUAN | 41 | |||
| BENCE JONES PROTEIN, UR | 1 | |||
| Benzene OSHA Exposure Panel | 5 | |||
| BENZO CONF GCMS | 5 | |||
| BENZO QN U | 5 | |||
| BENZODIAZEPINE VER G | 5 | |||
| BENZODIAZEPINE VERIF,GCMS | 4 | |||
| BENZODIAZEPINE, EXPANDED | 5 | |||
| BENZODIAZEPINES PANEL, B | 5 | |||
| BENZODIAZEPINES, SERUM | 5 | |||
| BEREP4, IHC W/O INTERP | 4 | |||
| BERMUDA GRASS (G2) IGE | 1 | |||
| BERYLLIUM, SERUM/PLASMA | 5 | |||
| BETA 2 MICROGLOBULIN, URI | 2 | |||
| BETA GLUCOSIDASE | 1 | |||
| BETA HCG, IHC W/O INTERP | 5 | |||
| BETA-2 GLYCOPROTEIN 1 AB | 326 | |||
| BETA-2 MICROGLOBULIN | 5 | |||
| BETA-2 TRANSFERRIN | 7 | |||
| BETA2-GLYCOPROTEIN (IGG) | 30 | |||
| BETA2-GLYCOPROTEIN I ANTI | 60 | |||
| BETA-GLOBIN COMPLETE | 8 | |||
| BETA-GLOGIN GENE DOSAGE | 5 | |||
| BETA-HYDROXYBUTYRATE | 2 | |||
| BICARBONATE, URINE | 5 | |||
| BILE ACIDS, FRACTIONATED | 5 | |||
| BILIRUBIN, BODY FLUID | 23 | |||
| BILIRUBIN, FRACTIONATED | 11 | |||
| BILIRUBIN, TOTAL | 5 | |||
| BILIRUBIN,DIRECT | 5 | |||
| BIOAGILYTIX GIARDIA AB | 5 | |||
| BIOTIN (B7) | 1 | |||
| BIRD FANCIER'S PREC PNL 1 | 2 | |||
| BK VIRUS DNA, QUAL RT-PCR | 11 | |||
| BK VIRUS DNA, QUANT RT-PC | 22 | |||
| BK VIRUS DNA, QUANT RT-PCR | 5 | |||
| BK VIRUS DNA,QUAL RT PCR | 18 | |||
| BK VIRUS DNA,QUANT RT PCR | 211 | |||
| BLACK PEPPER (F280) IGE | 1 | |||
| BLADDER CANCER, FISH | 172 | |||
| BLASTOMYCES AB PANEL, CF | 5 | |||
| BLASTOMYCES AB,IMMUNODIFF | 17 | |||
| BLASTOMYCES ANTIBODY PANE | 1 | |||
| BLOOD UREA NITROGEN, BODY | 5 | |||
| BLUE MUSSEL (F37) IGE | 2 | |||
| BLUEBERRY (RF288) IGE** | 2 | |||
| BOB1, IHC W/O INTERP | 5 | |||
| BORDETELLA PERTUS. IGG AB | 5 | |||
| BORDETELLA PERTUSSIS/PARA | 2 | |||
| BORDETELLA PT IGG | 1 | |||
| BORDETELLA, CULTURE | 5 | |||
| BORRELIA BURGDORFERI AB | 5 | |||
| BORRELIA SPECIES DNA, QL | 5 | |||
| BORRELIA SPP DNA, QL RT P | 200 | |||
| BRAC1/2 AND LYNCH W/CANCN | 5 | |||
| Brachyury Immunohistochemistry | 5 | |||
| BRAF MUTATION ANALYSIS | 10 | |||
| BRAF V600E IHC W/O I | 6 | |||
| BRAF, COBAS | 1 | |||
| BRAZIL NUT (F18) IGE | 41 | |||
| BRCA 1/2 PANEL | 5 | |||
| BRCA ASHKENAZI SCR W/RFL | 5 | |||
| BRCAVANTAGE(TM) PLUS | 5 | |||
| BRCAVANTAGE(TM), ASHKENA | 5 | |||
| BRCAVANTAGE(TM),COMPREHEN | 5 | |||
| BREAST CANCER STAT PANEL | 5 | |||
| BRIVARACETAM, S/P | 4 | |||
| BROCCOLI (F260) IGE | 5 | |||
| BRUCELLA AB,AGGLUTINATION | 5 | |||
| BRUCELLA ABS (IGG,IGM) | 6 | |||
| B-TYPE NATRIURETIC PEPTID | 5 | |||
| BUCKWHEAT (F11) IGE | 5 | |||
| BULLOUS PEMPHIGOID AG | 42 | |||
| BULLOUS PEMPHIGOID BP230 | 38 | |||
| BUP AND NAL QN, U | 5 | |||
| BUP, QN, URINE | 5 | |||
| BUPRENORPHINE SERUM | 16 | |||
| BUPROPION AND METABOLITE | 10 | |||
| C DIF TOXIN W/REFLEX TO PCR | 5 | |||
| C. HERBARUM (M2) | 2 | |||
| C1 ESTERASE INHIBTR,FUNCT | 40 | |||
| C1 INHIBITOR, FUNCTIONAL | 5 | |||
| C1 INHIBITOR, PROTEIN | 20 | |||
| C1R EVALUATION | 5 | |||
| C2 COMPLEMENT COMPONENT | 5 | |||
| C3 NEPHRITIC FACTOR | 5 | |||
| CA 15-3 | 17 | |||
| CA 19-9 | 838 | |||
| CA 19-9 PERITONEAL FLUID | 5 | |||
| CA 27.29 | 5 | |||
| CA-125 | 126 | |||
| CA125, IHC W/O INTERP | 5 | |||
| CA19-9, IHC W/O INTERP | 5 | |||
| CA27.29 | 35 | |||
| CABBAGE (F216) IGE | 5 | |||
| CADMIUM, 24 HOUR URINE | 1 | |||
| CADMIUM, BLOOD | 10 | |||
| CAFFEINE | 5 | |||
| CAH (21-HYDROXYLASE DEFIC | 5 | |||
| CALCITONIN | 62 | |||
| CALCITONIN, IHC W/INTERP | 5 | |||
| CALCITONIN,IHC W/O INTERP | 5 | |||
| CALCIUM | 5 | |||
| CALCIUM, IONIZED | 238 | |||
| CALCIUM,24-HOUR URINE | 5 | |||
| CALPROTECTIN, STOOL | 1038 | |||
| CALRETICULIN (CALR) MUTAT | 54 | |||
| CALRETININ,IHC W/O INTERP | 5 | |||
| CAMPYLOBACTER,CULTURE | 5 | |||
| C-ANCA TITER | 18 | |||
| CANCERNEXT® | 5 | |||
| CAR AUTOANTIBODY | 5 | |||
| CARB MTB | 5 | |||
| CARBAMAZEPINE | 5 | |||
| CARBAMAZEPINE & METABOLIT | 5 | |||
| CARBAMAZEPINE SENSITIVITY | 5 | |||
| CARBOHYDRATE-DEFICIENT | 79 | |||
| CARBOXYHEMOGLOBIN (B) | 22 | |||
| CARDIO IQ (TM) APOLIPOPRO | 1 | |||
| CARDIO IQ(R) APOE GENOTYP | 5 | |||
| CARDIO IQ(R) LIPOPROTEIN | 12 | |||
| CARDIO IQ(R) PROBNP, N- | 5 | |||
| CARDIO IQ(R) VIT D25, | 2654 | |||
| CARDIO IQ(TM) HS-CRP | 5 | |||
| CARDIO IQ(TM) LP-PLA2 (PL | 5 | |||
| CARDIOLIPIN AB, IGG IGM | 448 | |||
| CARDIOLIPIN ANTIBODIES | 44 | |||
| CARDIOLIPIN ANTIBODY IGA | 17 | |||
| CARISOPRODOL + MEPROBAMAT | 5 | |||
| CARNITINE, LC/MS/MS | 8 | |||
| CARNITINE,LC/MS/MS AND | 2 | |||
| CAROTENE | 77 | |||
| CARROT (F31) IGE | 1 | |||
| CASCADING REFLEX | 262 | |||
| CASEIN (F78) IGE | 2 | |||
| CASHEW NUT (F202) IGE | 44 | |||
| CASPR2 ANTIBODY TEST | 1 | |||
| CASPR2-IGG CBA, S | 5 | |||
| CAT DANDER (E1) IGE | 638 | |||
| CAT DANDER COMPONENT | 144 | |||
| CATECHOLAMINES FRACT. 24- | 23 | |||
| CATECHOLAMINES, FRACTIONA | 2 | |||
| CATECHOLEMINES,FRACTION,P | 116 | |||
| CATFISH IGE | 5 | |||
| CATHARTIC LAXATIVES PRF | 5 | |||
| CAULIFLOWER (RF291) IGE** | 5 | |||
| CBC (DIFF/PLT) | 10 | |||
| CBC(H/H,RBC,WBC,PLT) | 5 | |||
| CBFB/MYH11 INV(16) QUANT | 5 | |||
| CBG | 30 | |||
| CD10, IHC W/O INTERP | 32 | |||
| CD117-CKIT, IHC W/O INTER | 19 | |||
| CD123, IHC WITHOUT INTERP | 1 | |||
| CD138, IHC W/O INTERP | 34 | |||
| CD14, IHC WITHOUT INTERP. | 5 | |||
| CD15, IHC W/O INTERP | 6 | |||
| CD163, IHC WITHOUT INTERP | 1 | |||
| CD19, B CELLS | 20 | |||
| CD19, IHC WITH INTERP. | 5 | |||
| CD19, IHC WITHOUT INTERP. | 4 | |||
| CD1A, IHC W/O INTERP | 5 | |||
| CD2, IHC W/O INTERP. | 5 | |||
| CD20, IHC W/O INTERP | 13 | |||
| CD200 by Immunohistochemistry | 5 | |||
| CD21, IHC W/O INTERP. | 5 | |||
| CD23, IHC W/O INTERP | 1 | |||
| CD25, IHC W/O INTERP | 12 | |||
| CD3, IHC W/O INTERPRETA | 22 | |||
| CD30, IHC W/O INTERP | 7 | |||
| CD31, IHC W/O INTERP | 5 | |||
| CD34, IHC W/O INTERP | 2 | |||
| CD38, IHC W/O INTERP | 5 | |||
| CD4, IHC W/O INTERP | 1 | |||
| CD43, IHC W/O INTERP | 5 | |||
| CD44, IHC W/O INTERP. | 4 | |||
| CD45, IHC W/O INTERP | 2 | |||
| CD45RO (UCHL-1), IHC W/O INTERPRETATION | 5 | |||
| CD5, IHC W/O INTERP | 1 | |||
| CD56, IHC W/O INTERP | 10 | |||
| CD57, IHC W/O INTERP | 1 | |||
| CD61, IHC W/O INTERP | 1 | |||
| CD68, IHC W/INTERP | 5 | |||
| CD68, IHC W/O INTERP | 1 | |||
| CD7, IHC W/O INTERP | 1 | |||
| CD71, IHC W/O INTERP. | 2 | |||
| CD79A, IHC W/O INTERP | 5 | |||
| CD8, IHC W/O INTERP | 22 | |||
| CD99, IHC W/O INTERP | 35 | |||
| CDA Sequencing, V | 5 | |||
| CDKN1C Gene, Full Gene Analysis | 5 | |||
| CDX2, IHC WITHOUT INTERP. | 1 | |||
| CEA, MONOCLONAL IHC W/O INTERP | 5 | |||
| CEA, PANCREATIC CYST FLUI | 10 | |||
| CEA, PERITONEAL FLUID | 1 | |||
| CEA, POLYCLONAL, IHC W/IN | 5 | |||
| CEA, POLYCLONAL, IHC W/O | 5 | |||
| CEA,MONOCLONAL W/O INTERP | 5 | |||
| CEA,POLYCLONAL W/O INT~4 | 5 | |||
| CEA,POLYCLONAL W/O INTERP | 5 | |||
| CEBPA MUTATION ANALYSIS | 5 | |||
| CELERY (F85) IGE | 1 | |||
| CELIAC DISEASE COMP PANEL | 5 | |||
| CELIAC DISEASE COMPRE | 2 | |||
| CELIAC DISEASE PNL W/O GL | 13 | |||
| CELL CT AND DIFF,CSF | 2 | |||
| CENOBAMATE | 5 | |||
| CENTROMERE B ANTIBODY | 146 | |||
| CF GI PATHOGEN PANEL, PCR | 5 | |||
| CFTR INTRON 8 POLY-T ANAL | 5 | |||
| CFVANTAGE(TM) CF EXPANDED | 6 | |||
| CHARCOT-MARIE-TOOTH DISEASE | 5 | |||
| CHEDDAR CHEESE (F81) IGE | 1 | |||
| CHEESE MOZZARELLA IGE | 4 | |||
| CHEESE PROVOLONE IgE* | 5 | |||
| CHERRY (F242) IGE | 4 | |||
| CHICK PEA (F309) IGE | 1 | |||
| CHICKEN FEATHERS (E85) | 2 | |||
| CHICKEN MEAT (F83) IGE | 8 | |||
| CHIKUNGUNYA ANTIBODIES | 4 | |||
| CHIKUNGUNYA IGG TITRATION | 5 | |||
| CHIKUNGUNYA VIRUS RNA,QL | 5 | |||
| CHILI PEPPER (RF279) IG | 1 | |||
| CHILI PEPPER (RF279) IGE | 5 | |||
| CHLAMIDA TRACHOMATIS ANTI | 5 | |||
| CHLAMYDIA SPECIE IGG | 5 | |||
| CHLAMYDIA SPECIES AG, DFA | 5 | |||
| CHLAMYDIA TRACHOMATIS /N. | 2 | |||
| CHLAMYDIA TRACHOMATIS AB | 10 | |||
| CHLAMYDIA TRACHOMATIS CUL | 5 | |||
| CHLAMYDIA TRACHOMATIS RNA | 5 | |||
| CHLAMYDIA/CHLAMYDOPHILA | 10 | |||
| CHLAMYDIA/GC, RNA, TMA | 88 | |||
| CHLAMYDIA-GC, TMA, THROAT | 118 | |||
| CHLAMYDOPHILA PNEUMONIAE | 1 | |||
| CHLAMYDOPHILA PSITTACI AB | 5 | |||
| CHLORDIAZEPOXIDE AND META | 5 | |||
| CHLORPROMAZINE | 5 | |||
| CHOLESTEROL, TOTAL | 17 | |||
| CHOLINESTERASE PANEL | 5 | |||
| CHOLINESTERASE, SERUM | 2 | |||
| CHROM, LYMPH NODE | 2 | |||
| CHROMIUM SERUM | 14 | |||
| CHROMIUM, 24HR URINE | 5 | |||
| CHROMIUM, PLASMA | 13 | |||
| CHROMIUM,BLOOD | 6 | |||
| CHROMOGRANIN A | 145 | |||
| CHROMOGRANIN A, REBASEL | 5 | |||
| CHROMOGRANIN,IHC W/O INT | 2 | |||
| CHROMOGRANIN,IHC W/OIN~2 | 5 | |||
| CHROMOSOMAL MICROARRAY | 5 | |||
| CHROMOSOME ANALY BL NO GR | 5 | |||
| CHROMOSOME ANALYSIS BLOOD | 22 | |||
| CHROMOSOME ANALYSIS TISSU | 5 | |||
| CHROMOSOME ANALYSIS, BLD | 5 | |||
| CHROMOSOME ANALYSIS, CLL/ | 5 | |||
| CHROMOSOME ANALYSIS, HEMA | 142 | |||
| CHROMOSOME ANALYSIS, HIGH | 5 | |||
| CHROMOSOME FISH, CBFB FOR | 5 | |||
| CHRONIC URTICARIA PANEL | 74 | |||
| CHRONIC URTICARIA PNL 2 | 2 | |||
| CHYMOTRYPSIN, STOOL | 54 | |||
| CINNAMON (RF220) IGE** | 5 | |||
| CITALOPRAM | 1 | |||
| CITRIC ACID 24-HR URINE | 25 | |||
| CITRIC ACID,24HR (W/O CRE | 46 | |||
| CK, TOTAL | 10 | |||
| CK14, IHC W/O INTERP | 5 | |||
| CK17, IHC W/O INTERP | 5 | |||
| C-KIT MUTATION ANALYSIS, | 5 | |||
| CLAM (F207) IGE | 46 | |||
| CLARETININ, IHC W/O INTERP | 5 | |||
| CLL, IGVH MUTATION STATUS | 52 | |||
| CLOBAZAM AND METABOLITE, | 2 | |||
| CLOMIPRAMINE | 5 | |||
| CLONAZEPAM & METAB CNF | 7 | |||
| CLONAZEPAM & METAB SCR | 242 | |||
| CLONAZEPAM (KLONOPIN) | 10 | |||
| CLONAZEPAM AND 7-AMINO | 5 | |||
| CLONIDINE,SER/PLASMA | 5 | |||
| CLOSTRIDIUM DIFFICILE CYT | 2 | |||
| CLOSTRIDIUM DIFFICILE TOX | 2 | |||
| CLOZAPINE | 326 | |||
| CMV ANTIBODY (IGG) | 131 | |||
| CMV IHC W/INTERP | 1 | |||
| CMV IHC W/O INTERP | 5 | |||
| CMV PCR Qual | 5 | |||
| CMV,CONVENTIONAL & RAPID | 5 | |||
| CN1A AB (IGG) | 34 | |||
| CNBP DNA TEST (DM2) | 1 | |||
| COBALT, BLOOD | 18 | |||
| COBALT, RANDOM URINE | 5 | |||
| COBALT,SERUM/PLASMA | 14 | |||
| COCAINE GCMS B/S/P | 2 | |||
| COCAINE MET QN U | 5 | |||
| COCCIDIO AB, ID | 5 | |||
| COCCIDIOIDES AB TO TP AND | 36 | |||
| COCCIDIOIDES AB, CF | 12 | |||
| COCCIDIOIDES AB,IMMUNODIF | 13 | |||
| COCCIDIOIDES AG | 2 | |||
| COCKATIEL FEATHERS IGE | 5 | |||
| COCKROACH AMERICAN | 631 | |||
| COCOA (F93) IGE | 5 | |||
| COCONUT (F36) IGE | 5 | |||
| CODEINE BY GCMS | 5 | |||
| CODFISH (F3) IGE | 42 | |||
| COENZYME Q10 | 5 | |||
| COFFEE (RF221) IGE** | 1 | |||
| COLBAZAM & METABOLITE, | 5 | |||
| COLD AGGLUTININS | 52 | |||
| COLLAGEN CROSS-LINKED | 112 | |||
| COLLAGEN TYPE I C-TELOPEP | 388 | |||
| COLLAGEN TYPE II AB,SERUM | 2 | |||
| COLLAGEN TYPE VII AB IGG | 5 | |||
| COLORECTAL CANCER MUT | 8 | |||
| Combined Cardiac Sequencing and Deletion/Duplication | 5 | |||
| COMP DYSTONIA+MTDNA(MNG) NGS358 | 5 | |||
| COMP LYSOSOMAL STORAGE PANEL | 5 | |||
| COMP METAB PNL | 4 | |||
| COMP. OPHTHALMOPHEGIA | 5 | |||
| COMPLEMENT C5 | 5 | |||
| COMPLEMENT COMPONENT C1Q | 13 | |||
| COMPLEMENT COMPONENT C6,S | 5 | |||
| COMPLEMENT,TOTAL (CH50) | 175 | |||
| COMPREHENSIVE CARRIER SCREEN | 5 | |||
| COMPREHENSIVE INHALENT AL | 5 | |||
| COMPREHENSIVE MD GENES | 5 | |||
| COMPREHENSIVE NEUROPATHIES | 5 | |||
| Comprehensive Neuropathies NextGen Sequencing Pane | 5 | |||
| CONF AMP, ORAL FL | 5 | |||
| CONF BARB, ORAL FL | 5 | |||
| CONF BENZO, ORAL FL | 5 | |||
| CONF COC, ORAL FL | 5 | |||
| CONF FENT, OR | 5 | |||
| CONF ME, ORAL FL | 5 | |||
| CONF MEPR, ORAL FL | 5 | |||
| CONF NIC, ORAL FL | 5 | |||
| CONF OPI, ORAL F | 5 | |||
| CONF OPI, ORAL FL | 5 | |||
| CONF THC, ORAL FL | 5 | |||
| CONF TRAM, OR | 5 | |||
| CONF ZOL, ORAL FL | 5 | |||
| COPEPTIN | 22 | |||
| COPPER | 1220 | |||
| COPPER, 24 HR URINE | 16 | |||
| COPPER, BLOOD | 5 | |||
| COPPER, LIVER TISSUE | 5 | |||
| COPPER, RANDOM URINE | 6 | |||
| COPPER, SERUM OR PLASMA | 5 | |||
| COPPER-FREE,SERUM/PLASMA | 5 | |||
| CORECEPTOR TROPISM W/RFL | 5 | |||
| CORIANDER/CILANTRO (F317) | 5 | |||
| CORN (F8) IGE | 1 | |||
| CORNEAL DYSTROPHIES PANEL | 5 | |||
| CORTICOTROPIN REL. FACTOR | 1 | |||
| CORTISOL FREE & CORTISONE | 2 | |||
| CORTISOL FREE, 24HR URINE | 108 | |||
| CORTISOL, A.M. | 5 | |||
| CORTISOL, FREE, 24HR UR | 28 | |||
| CORTISOL, LC/MS/MS, SALIV | 109 | |||
| CORTISOL, LMC/MS/MS, SALI | 4 | |||
| CORTISOL, TOTAL | 5 | |||
| CORTISOL,FREE,LC/MS/MS | 46 | |||
| CORTISONE, 24HR URINE | 2 | |||
| COW'S MILK (F2) IGE | 35 | |||
| COWS MILK(F2)IGE RFL | 1 | |||
| COX2, IHC WITHOUT INTERP. | 5 | |||
| COXIELLA BURNETII DNA, | 2 | |||
| COXSACKIE A ANTIBODIES, S | 5 | |||
| COXSACKIE B (1-6) ANTIB | 5 | |||
| C-PEPTIDE | 614 | |||
| CRAB (F23) IGE | 49 | |||
| CRAYFISH | 5 | |||
| CRBF CREAT PERICARD | 5 | |||
| C-REACTIVE PROTEIN | 1 | |||
| CREAM CHEESE IGE | 5 | |||
| CREATINE KINASE ISOENZYME | 125 | |||
| CREATINE KINASE(CK) ISOEN | 1 | |||
| CREATINE, 24HR (U) | 1 | |||
| CREATININE | 6 | |||
| CREATININE RAND (U) | 6 | |||
| CREATININE, BF | 5 | |||
| CRP | 1 | |||
| CRYOFIBRINOGEN | 16 | |||
| CRYOGLOBULIN REFLEX | 5 | |||
| CRYOGLOBULIN SCREEN | 5 | |||
| CRYOGLOBULIN, QUALITATIVE | 56 | |||
| CRYOGLOBULIN, SERUM | 84 | |||
| CRYOGLOBULINS,QUANT. | 5 | |||
| CRYPTOCOCCAL ANTIGEN | 22 | |||
| CRYPTOSPORIDIUM AG, DFA | 252 | |||
| CSF CHLORIDE | 5 | |||
| CSF IMMUNOGLOBULINS | 1 | |||
| CSF, VDRL | 35 | |||
| CSM HYBRID DRUG PROFILE | 5 | |||
| CT RNA,TMA,UROGEN | 5 | |||
| CT/GC RNA,TMA RFLX TO ALT | 1 | |||
| CT/GC RNA,TMA,CONJUN | 1 | |||
| CUCUMBER (F244) IGE | 4 | |||
| CULT, (U) ROUTINE | 1 | |||
| CULT, FUNGUS (B) | 7 | |||
| CULTURE FUNGUS, MISC. | 133 | |||
| CULTURE, AEROBIC AND ANAE | 5 | |||
| CULTURE, AEROBIC BAC | 5 | |||
| CULTURE, CSF | 1 | |||
| CULTURE, FUNGUS, BLD. | 2 | |||
| CULTURE, FUNGUS, SKIN, | 37 | |||
| CULTURE, YEAST WITH ID | 5 | |||
| CULTURE,WOUND,SUPERFICIAL | 2 | |||
| CUMIN IGE | 5 | |||
| CUTANEOUS DIRECT IMMUNOFL | 2 | |||
| CV2 AUTOANTIBODY TEST | 5 | |||
| CYANIDE, BLOOD | 1 | |||
| CYCLIC CITRULLINATED | 72 | |||
| CYCLIN D1 (BCL-1), IHC W/O INTERPRETATION | 5 | |||
| CYCLIN D1 IHC W/O INTERP | 28 | |||
| CYCLOSP TR FPIA | 70 | |||
| CYCLOSPORA AND ISOSPORA | 22 | |||
| CYCLOSPORINE A TROUGH, | 30 | |||
| CYCLOSPORINE A TROUGH,BLO | 7 | |||
| CYSTATIN C | 5 | |||
| CYSTATIN C W/EGFR | 4 | |||
| CYSTIC FIBROSIS | 5 | |||
| CYSTIC FIBROSIS CF | 5 | |||
| CYSTIC FIBROSIS COMPLETE | 5 | |||
| CYSTIC FIBROSIS DEL/DUP | 5 | |||
| CYSTIC FIBROSIS SCREEN | 5 | |||
| CYSTIC FIBROSIS,CARRIER | 10 | |||
| CYSTICERCOS ANTIBODY | 5 | |||
| CYSTICERCUS IGG AB | 5 | |||
| CYSTICERCUS IGG AB CSF | 5 | |||
| CYSTICERCUS IGG ANTIBODY, | 2 | |||
| CYSTINE, 24 HR URINE | 19 | |||
| CYSTINE, QNT R UR W/CREAT | 1 | |||
| CYTO,NON-GYN,LIQ,TC1 | 5 | |||
| CYTOCHROME P450 2D6 GENO | 5 | |||
| CYTOKERATIN 18, IHC W/O I | 5 | |||
| CYTOKERATIN 19, IHC W/O I | 5 | |||
| CYTOKERATIN 20, IHC W/O I | 1 | |||
| CYTOKERATIN 5/6 W/O INTER | 14 | |||
| CYTOKERATIN 7, IHC W/O IN | 13 | |||
| CYTOKERATIN 8 & 18 W/O IN | 5 | |||
| CYTOKERATIN AE1/AE3 W/O I | 7 | |||
| CYTOKERATIN AE1/AE3, W/IN | 5 | |||
| CYTOKINE PANEL 13,S | 5 | |||
| CYTOLOGY,BODY FLUIDS | 11 | |||
| CYTOMEGALOVIRUS ABS | 85 | |||
| CYTOMEGALOVIRUS ANTIBODIE | 127 | |||
| CYTOMEGALOVIRUS ANTIVIRAL | 5 | |||
| CYTOMEGALOVIRUS CULTURE | 1 | |||
| CYTOMEGALOVIRUS DNA,QUAL | 2 | |||
| CYTOMEGALOVIRUS DNA,QUANT | 85 | |||
| CYTOMEGALOVIRUS W/INTERP | 5 | |||
| CYTOMEGALOVIRUS, IHC W/O INTERP | 5 | |||
| D. FARINAE (D2) | 636 | |||
| D. PTERONYSSINUS (D1) | 628 | |||
| D2-40, IHC WITHOUT INTERP | 5 | |||
| DABIGATRAN W/REFL TT | 5 | |||
| DATE (TREE) T214 IGE | 5 | |||
| DBA44 HAIRY CELL, W/O INT | 1 | |||
| D-DIMER QN | 5 | |||
| DEFINITIVE 1 W/ EXP OPI | 68 | |||
| DEFINITIVE 2 W/ EXP OPI | 36 | |||
| DEFINITIVE 3 W/ EXP OPI | 4 | |||
| DEFINITIVE 4 W/ EXP OPI | 1 | |||
| DEFINITIVE 5 W/ EXP OPI | 1 | |||
| DEFINITIVE 6 W/ EXP OPI | 1 | |||
| DEFINITIVE TEST 01 | 6600 | |||
| DEFINITIVE TEST 02 | 256 | |||
| DEFINITIVE TEST 03 | 92 | |||
| DEFINITIVE TEST 04 | 68 | |||
| DEFINITIVE TEST 05 | 35 | |||
| DEFINITIVE TEST 06 | 7 | |||
| DEFINITIVE TEST 07 | 1 | |||
| DELTA AMINOLEVULINIC ACID | 1 | |||
| DENGUE FEVER AB (IGG,IGM) | 8 | |||
| DENGUE VIRUS RNA, RT PCR | 1 | |||
| DEOXYCORTICOSTERONE | 1 | |||
| DESMIN, IHC W/O INTERP | 1 | |||
| DESMOGLEIN ANTIBODIES | 13 | |||
| DEXAMETHASONE | 203 | |||
| DEXAMETHASONE SUPPRESSION | 29 | |||
| DEXTRO/LEVO METHORPHAN | 5 | |||
| DEXTRO/LEVO METHORPHAN, U | 24 | |||
| DHEA (DEHYDROEPIANDROSTER | 37 | |||
| DHEA SULFATE | 388 | |||
| DHT LCMSMS | 5 | |||
| DIAZEPAM AND METABOLITE | 2 | |||
| DIGITOXIN, SERUM/PLASMA | 1 | |||
| DIHYDROPYRIMIDINE DEHYDRO | 5 | |||
| DIHYDROTESTOSTERONE, FREE | 5 | |||
| DILTIAZEM, SERUM/PLASMA | 5 | |||
| DIPHENYDRAMINE, URINE | 5 | |||
| DIPHTHERIA AND TETANUS | 11 | |||
| DIPHTHERIA ANTITOXOID | 34 | |||
| DIRECT ANTIGLOBULIN TEST | 5 | |||
| DIRECT LDL | 10 | |||
| DIURETIC SCREEN | 5 | |||
| DIURETICS PNL,SERUM/PLASM | 5 | |||
| D-LACTATE, PLASMA | 4 | |||
| DLD DEFICIENCY | 1 | |||
| DM ALC METAB U | 2315 | |||
| DM AMPHETAMINES QN U | 296 | |||
| DM BARBITURATES QN U | 37 | |||
| DM BENZO QN U | 352 | |||
| DM BUP AND NAL QN, U | 113 | |||
| DM COCAINE MET QN U | 91 | |||
| DM FENTANYL,QN,U | 1277 | |||
| DM GABAPENTIN,QN,U | 14 | |||
| DM HEROIN METAB,QN,U | 61 | |||
| DM MARIJUANA M QN U | 396 | |||
| DM MDMA/MDA,QN,U | 179 | |||
| DM ME METAB QN U | 19 | |||
| DM MEPERIDINE,QN,U | 58 | |||
| DM MPHENIDATE M,QN,U | 2107 | |||
| DM NPS QN,U | 390 | |||
| DM OPI EXPANDED QN U | 245 | |||
| DM SYNTH CANNAB | 88 | |||
| DM TAPENTADOL,QN,U | 5 | |||
| DM TRAMADOL,QN,U | 284 | |||
| DM ZOLPIDEM QN, UR | 4 | |||
| DM,PHOSPHATIDYELTH,B | 409 | |||
| DMPK DNA TEST (DMI) | 1 | |||
| DNA (DS) ANTIBODY | 5 | |||
| DNASE-B ANTIBODY | 6 | |||
| DOG DANDER (E5) IGE | 637 | |||
| DOG DANDER COMPONENT | 136 | |||
| DOG1, IHC W/O INTERP | 5 | |||
| DONOR HLA AB SCRN I & II | 5 | |||
| DONOR, HEPATITIS C AB,(AN | 5 | |||
| DOXEPIN | 1 | |||
| DOXEPIN, QUANT. | 5 | |||
| DRAW FEE, PSC SPEC. | 15934 | |||
| DRUG ABUSE PANEL 8, W CON | 26 | |||
| DRUG ABUSE SCREEN | 36 | |||
| DRUG ABUSE SCRN-5 SERUM | 2 | |||
| DRUG BUP AND NAL QN, U | 5 | |||
| DRUG COCAINE MET QN U | 5 | |||
| DRUG DEPENDENT PLATELET AB | 5 | |||
| DRUG MONITOR, NPS, QL, U | 2 | |||
| DRUG SCRN CLIN 1 (S) | 5 | |||
| Drug Toxicology Monitoring 1, with Confirmation, Oral Fluid | 5 | |||
| Drug Toxicology Monitoring Alcohol Metabolites, Quantitative, Urine | 5 | |||
| DRVVT 1:1 MIX | 19 | |||
| DRVVT CONFIRMATION | 85 | |||
| DRVVT SCREEN W/RELEX | 5 | |||
| DS-DNA ANTIBODY CRITHIDIA | 2 | |||
| DTM CONF AMP, ORAL FL | 2 | |||
| DTM CONF BENZO, ORAL FL | 7 | |||
| DTM CONF COC, ORAL FL | 6 | |||
| DTM CONF ME, ORAL FL | 26 | |||
| DTM CONF MEPR, ORAL FL | 1 | |||
| DTM CONF NIC, ORAL FL | 20 | |||
| DTM CONF OPI, ORAL FL | 11 | |||
| DTM CONF THC, ORAL FL | 5 | |||
| DTM ORAL FL TEST 06 | 1 | |||
| DTM ORAL FL TEST 12 | 370 | |||
| DUCK FEATHERS (E86) IGE | 1 | |||
| DULOXETINE, SERUM/PL | 4 | |||
| DUPLICATE SLIDES | 132 | |||
| DUST ALLERGY PANEL # 1 | 5 | |||
| E.EQUINE ENCEPH VIRUS IGM | 1 | |||
| E.EQUINE ENCEPHAL VIRUS | 1 | |||
| E.HISTOLYTICA IGG, ELISA | 11 | |||
| EASTERN EQUINE ENCEPHALIT | 2 | |||
| EBV CAPSID AG (VCA) IGM | 2 | |||
| EBV CAPSID AG(VCA) AB IGG | 5 | |||
| EBV DNA QUAL. PCR | 5 | |||
| EBV IHC W/O INTERP | 5 | |||
| EBV ISH W/O INTERP | 4 | |||
| EBV QUANT | 5 | |||
| EBV, ISH WITH INTERP. | 5 | |||
| E-CADHERIN, IHC W/O INTER | 32 | |||
| E-CADHERIN, IHC W/O INTER | 5 | |||
| ECHINOCOCCUS AB (IGG) WB | 5 | |||
| ECHINOCOCCUS AB IGG WITH | 5 | |||
| ECHOVIRUS AB PANEL-SERUM | 1 | |||
| ECHOVIRUS ANTIBODIES, CSF | 5 | |||
| EGFR MUT SOLID TUMOR | 5 | |||
| EGG COMPONENT PANEL | 2 | |||
| EGG WHITE (F1) IGE | 19 | |||
| EGG YOLK (F75) IGE | 19 | |||
| EGGPLANT (RF262) IGE** | 5 | |||
| EHLERS-DANLOS SYNDROME PANEL | 5 | |||
| EHRLICHIA CHAFFEEN AB G/M | 102 | |||
| EHRLICHIA CHAFFEENSIS | 5 | |||
| EHRLICHIA CHAFFEENSIS DNA | 84 | |||
| EHRLICHIA EWINGII DNA,RT | 6 | |||
| ELECTROLYTE PANEL | 5 | |||
| ELECTROLYTES, FECES | 26 | |||
| ELECTROPHORESIS, PROTEIN | 5 | |||
| ELF SCORE | 11 | |||
| EMA, IHC W/O INTERP | 4 | |||
| EML4-ALK GENE FUSION, PCR | 5 | |||
| ENA PROFILE | 5 | |||
| ENCEPH,AUTOIMM/PARANEO, CSF | 5 | |||
| ENCEPHALITIS AB PNL CSF | 5 | |||
| ENCEPHALITIS AB PNL,CSF | 1 | |||
| ENCEPHALITIS AB W/R | 10 | |||
| ENCEPHALITIS AB, CSF | 10 | |||
| ENCEPHALOPATHY EVAL | 5 | |||
| ENCEPHALOPATHY,AUTO,CSF | 5 | |||
| ENDOMYSIAL AB TITER | 2 | |||
| ENDOMYSIAL ANTIBODY SCRN. | 66 | |||
| ENGLISH PLANTAIN (W9) IGE | 5 | |||
| ENTAMOEBA HISTOLYTICA ANT | 2 | |||
| ENTEROVIRUS PANEL, CF, SE | 5 | |||
| ENTEROVIRUS RNA, QUAL. | 5 | |||
| ENTEROVIRUS/PARECHOVIRUS | 5 | |||
| EOSINOPHIL CATIONIC PROTE | 5 | |||
| EOSINOPHIL COUNT (U) | 5 | |||
| EPHEDRINE QUANTITATION | 5 | |||
| EPHEDRINES PANEL, URINE | 5 | |||
| EPIDERMAL ABS W/REFLEX | 1 | |||
| EPIDERMAL GROWTH FACTOR | 5 | |||
| EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS | 5 | |||
| EPITHELIAL MEMBRANE AG IHC W/O INTERP | 5 | |||
| EPSTEIN BARR VIRUS (EBV) ISH, WITHOUT INTERP | 5 | |||
| EPSTEIN BARR VIRUS AB PNL | 154 | |||
| EPSTEIN BARR VIRUS, DNA | 184 | |||
| EPSTEIN-BARR VIRUS ANTIBO | 8 | |||
| EPSTEIN-BARR VIRUS, EARLY | 5 | |||
| EPSTEIN-BARR VIRUS, ISH w/o INTERP. | 5 | |||
| EPSTEIN-BARR VIRUS, ISH WITH INTERPRETATION | 5 | |||
| EPSTIEN-BARR VIRUS NUCLEA | 5 | |||
| ER IHC W/O INTERP | 5 | |||
| ER, IHC W/INTERP | 5 | |||
| ER/PR, PARAFFIN BLOCK | 5 | |||
| ER/PR/HER2 W/REFLEX HER2 | 5 | |||
| ERG, IHC W/O INTERP | 5 | |||
| ERYTHROCYTE PORPHYRIN | 5 | |||
| ERYTHROPOIETIN(EPO) | 1038 | |||
| ESLICARBAZEPINE | 5 | |||
| ESOTERIX MYOMARKER 3 PNL | 5 | |||
| ESTRADIOL | 941 | |||
| ESTRADIOL ULTRA SENSITIVE | 198 | |||
| ESTRADIOL,FREE,LC/MS/MS | 7 | |||
| ESTRIOL, LC/MS/MS, SERUM | 5 | |||
| ESTROGEN RECEPTOR (ER) IHC, W/O INTERP | 5 | |||
| ESTROGENS, FRACT. LCMSMS | 196 | |||
| ESTROGENS, TOTAL | 137 | |||
| ESTRONE, LC/MS/MS | 18 | |||
| E-TEST MIC;S.A.17649 | 5 | |||
| ETG/ETS CONFIRMATION | 5 | |||
| ETHOSUXIMIDE | 1 | |||
| ETHYL ALCOHOL, URINE | 5 | |||
| ETHYLENE GLYCOL | 12 | |||
| ETHYLENE GLYCOL, S/B/P | 5 | |||
| EUGLOBULIN CLOT LYSIS TIM | 1 | |||
| EVEROLIMUS, BLOOD | 30 | |||
| EXOME NEXT PROBAND PUS MTDNA | 5 | |||
| EXT MYOSITIS SPEC AB PNL | 157 | |||
| F. MONILIFORME (M9) | 5 | |||
| F. TULARENSIS AB, S | 1 | |||
| FACTOR 13A W/O INTERP | 8 | |||
| FACTOR H (B1H) LEVEL | 5 | |||
| FACTOR II ACTIVITY | 7 | |||
| FACTOR IX ACTIVITY | 8 | |||
| FACTOR IX ACTIVITY AND | 4 | |||
| FACTOR V ACTIVITY | 24 | |||
| FACTOR V ACTIVITY AND | 4 | |||
| FACTOR VII ACTIVITY | 12 | |||
| FACTOR VIII ACTIVITY,CL | 96 | |||
| FACTOR VIII ACTIVITY,CLOT | 5 | |||
| FACTOR VIII ANTIGEN | 4 | |||
| FACTOR VIII INHIBITOR PNL | 10 | |||
| FACTOR X ACTIVITY | 11 | |||
| FACTOR X1 ACTIVITY AND | 1 | |||
| FACTOR XI | 2 | |||
| FACTOR XII ACTIVITY | 2 | |||
| FACTOR XIII FUNCTIONAL | 2 | |||
| FAMILIAL HYPOCALCIURIC | 5 | |||
| FAMILIAL MEDITERRANEAN | 1 | |||
| FATTY ACIDS, FECAL TOTAL | 11 | |||
| FEATHER PANEL #2 | 630 | |||
| FECAL FAT, QUAL | 178 | |||
| FECAL GLOBIN BY IMMUNOCHE | 5 | |||
| FECAL IMMUNOCHEM | 5 | |||
| FENTANYL AND NORFENTANYL | 5 | |||
| FENTANYL,QN,U | 5 | |||
| FERRITIN | 2 | |||
| FGF 23 | 5 | |||
| FGF-23 (FIBROBLAST GROWTH | 5 | |||
| FH PANEL | 4 | |||
| FH SEQUENCING AND DEL/DUP | 5 | |||
| FIBRILLARIN(U3 RNP) | 5 | |||
| FIBRIN MONOMER | 1 | |||
| FIBRINOGEN ACTIVITY,CLAUS | 18 | |||
| FIBRINOGEN ANTIGEN, NEPH | 2 | |||
| FIBRINOGEN DEGRADATION PR | 5 | |||
| FILARIA ANTIBODY (IGG4) | 7 | |||
| FIRE ANT (I70) IGE | 2 | |||
| FISH -5 OR 5Q- | 1 | |||
| FISH AML1/ETO T 8;21 | 6 | |||
| FISH DEL 13Q | 5 | |||
| FISH FOLLICULAR LYMPHOMA, | 1 | |||
| FISH X LINKED ICHTHYOSIS | 1 | |||
| FISH, ALL, PRE-B | 5 | |||
| FISH, ALL/NHL, MYC-BA,8q24 REARRANGEMENT | 5 | |||
| FISH, AML M3, RARA BA | 5 | |||
| FISH, AML M4, CBFB/MYH11 | 7 | |||
| FISH, B-CELL CHRONIC | 37 | |||
| FISH, BURKITT, T(8;14) | 1 | |||
| FISH, CHROMOSOME 2 | 1 | |||
| FISH, CLL, ATM DEL | 11 | |||
| FISH, CLL, TRISOMY 12 | 10 | |||
| FISH, CML/ALL BCR/ABL | 54 | |||
| FISH, EWING/PNET, EWSR1 | 5 | |||
| FISH, FGFR1, 8P11-12 | 5 | |||
| FISH, HER2/NEU REFL IHC | 5 | |||
| FISH, HER-2/NEU,PARAF | 7 | |||
| FISH, HES/LEUKEMIA | 2 | |||
| FISH, IGH/CCND1, T(11;14) | 7 | |||
| FISH, LOCUS SPECIFIC PROBE X2 | 5 | |||
| FISH, LOCUS SPECIFIC PROBE XI | 5 | |||
| FISH, LOCUS-SPECIFIC PROB | 26 | |||
| FISH, MALT LYMPH,REA18Q21 | 5 | |||
| FISH, MALT LYMPH,T(11;18) | 5 | |||
| FISH, MDS PANEL | 72 | |||
| FISH, MECOM (EVI1),3Q26.2 | 5 | |||
| FISH, MET AMPLIFICATION | 5 | |||
| FISH, MM, IGH/MAFB, T(14; | 5 | |||
| FISH, MPN (EOSINOPHILIA) | 1 | |||
| FISH, MULTIPLE MYELOMA | 5 | |||
| FISH, MYC-BA, 8Q24 | 1 | |||
| FISH, MYELOMA, IGH PANEL | 13 | |||
| FISH, MYELOMA, RISK ASSES | 1 | |||
| FISH, NHL, BCL6 | 5 | |||
| FISH, P53 | 23 | |||
| FISH, PDGFRB, 5Q33.1 | 2 | |||
| FISH, SYNOVIAL,SYT | 2 | |||
| FISH, T CELL RECEPTOR | 1 | |||
| FISH, TCL1, 14Q32.1 | 5 | |||
| FISH,AML M3,PML/RARA | 5 | |||
| FISH,AML/MDS,-7/DE | 1 | |||
| FISH,AML/MDS,CEP8, | 1 | |||
| FISH,APL,PML/RARA,TRANSLO | 7 | |||
| FISH,ARMS,FKHR,13Q14 | 5 | |||
| FISH,MANTLE CELL LYMPHOMA | 5 | |||
| FISH,MDM2/CEP 12 | 1 | |||
| FISH,MLL,11Q23 REARRANGE | 5 | |||
| FISH,MYELOMA,17P-,REA 14Q | 52 | |||
| FLAXSEED/LINSEED IGE | 5 | |||
| FLCN SEQ AND DEL/DUP | 1 | |||
| FLECAINIDE (TAMBOCOR TM) | 1 | |||
| FLT3 ITD AND TKD MUTATION LABPMM | 5 | |||
| FLUCONAZOLE - ANTIFUNGAL | 5 | |||
| FLUCONAZOLE, LC/MS/MS | 5 | |||
| FLUNITRAZEPAM & META,UR | 1 | |||
| FLUORIDE, PLASMA | 5 | |||
| FLUOXETINE | 1 | |||
| FLUPHENAZINE, SERUM/PLASM | 1 | |||
| FLUVOXAMINE, SERUM/PLASMA | 5 | |||
| FOLATE, RBC | 55 | |||
| FOLATE,SERUM | 1 | |||
| FONDAPARINUX SODIUM (XA) | 1 | |||
| FOOD ALLERGY PROFILE, | 186 | |||
| FORMALDEHYDE | 1 | |||
| FORMIC ACID, S/P | 5 | |||
| FRAC. CATECHOLAMINES W/CR | 112 | |||
| FRAGILE X METHYLATION | 4 | |||
| FRANCISELLA TULARENSIS | 5 | |||
| FREE FATTY ACIDS | 5 | |||
| FREE PHENYTOIN | 22 | |||
| FREE T3 | 5 | |||
| FRUCTOSAMINE | 1148 | |||
| FSH | 5 | |||
| FSH & LH (S) | 5 | |||
| FSHD SOUTHERN BLOT TEST | 1 | |||
| FSHD-(FSHD1 and FSHD2) Abnormal Alleles w/Interp | 5 | |||
| FSHD1 AND FSHD | 5 | |||
| FSHD1 SOUTHERN BLOT | 1 | |||
| FTA-ABS | 38 | |||
| FUGITELL | 1 | |||
| FUNGAL AB PANEL, SERUM | 5 | |||
| FUNGAL ID MOLD | 5 | |||
| FUNGAL IDENTIFICATION | 1 | |||
| FUNGAL PANEL 1, ID | 5 | |||
| FUNGAL PANEL 1, IMMUNODIF | 35 | |||
| FUNGAL SEQUENCING, | 5 | |||
| FUNGAL STAIN, CALCOFLUOR | 5 | |||
| FUNGITELL (R)(1-3)-B-D | 283 | |||
| FUNGITELL(R), BAL | 1 | |||
| FUNGUS CULTURE AND SMEAR | 109 | |||
| FUNGUS SMEAR | 5 | |||
| G-6-PD.QUANT. | 166 | |||
| GABAPENTIN | 31 | |||
| GABAPENTIN,QN,U | 5 | |||
| GAD-65 AB | 284 | |||
| GAD65 NEURO SYND AB | 2 | |||
| GAD65,1A-2, & INSULIN | 10 | |||
| GALACTOSE-ALPHA1,3-GALACT | 5 | |||
| GAMMA-HYDROXYBUTYRIC ACID | 1 | |||
| GANGLIONIC NACHR AB TEST | 12 | |||
| GANGLIOSIDE AB PANEL 6 | 29 | |||
| GANGLIOSIDE GQ1B AB IGG | 16 | |||
| GARLIC (F47) IGE | 4 | |||
| GASTRIC PARIETAL CELL A | 5 | |||
| GASTRIC PARIETAL CELL AB | 5 | |||
| GASTRIN IHC W/INTERP | 5 | |||
| GASTRIN, IHC W/O INTERP | 5 | |||
| GASTRIN, RIA | 60 | |||
| GATA3, IHC W/O INTER | 25 | |||
| GAUCHER DISEASE, DNA | 5 | |||
| GCDFP-15 IHC W/O INTERP | 5 | |||
| GELATIN BOVINE IGE | 5 | |||
| GEN TOX LCMSMS SP | 5 | |||
| GEN TOX URINE | 715 | |||
| GENOME CHROMOSOMAL MICROARRA | 5 | |||
| GENOMEDX: WHOLE-GENOME CHROM | 5 | |||
| GENOTYPE/PHENOTYPE REVIEW | 14 | |||
| GFAP, IHC W/O INTERP | 5 | |||
| GGT | 5 | |||
| GHRELIN, TOTAL | 5 | |||
| GI PATH PNL PCR | 18 | |||
| GIARDIA & CRYPTO ANTIGEN | 139 | |||
| GIARDIA ANTIBODY, IFA | 5 | |||
| GIARDIA ANTIGEN, EIA | 343 | |||
| GIARDIA LAMBLIA IgA/IgG/IgM | 5 | |||
| GIARDIA LAMBLIA IGG AB | 5 | |||
| GINGER (RF270) IGE** | 5 | |||
| GLIADIN ANTIBODY (IGG,IGA | 29 | |||
| GLIADIN/GLUTEN IGA ANTIBO | 5 | |||
| GLIAL FIBRILLARY ACIDIC PROTEIN, IHC W/O INTERP | 5 | |||
| GLOMERULAR BASEMENT | 66 | |||
| GLUCAGON | 16 | |||
| GLUCOSE, CSF | 2 | |||
| GLUCOSE, SERUM | 5 | |||
| GLUCOSE, SYNOVIAL FLUID | 37 | |||
| GLUCOSE,PERICARDIAL FLUID | 6 | |||
| GLUT-1 IHC | 5 | |||
| GLUTAMIC ACID DECARBOXY- | 5 | |||
| GLUTEN (F79) IGE | 2 | |||
| GLUTEN IGG | 2 | |||
| GLUTETHIMIDE | 5 | |||
| GLYCOHEMOGLOBIN, HBA1C | 5 | |||
| GLYCOPHORIN A W/O INTERP | 1 | |||
| GLYPICAN 3, IHC W/INTERP. | 5 | |||
| GLYPICAN 3, IHC W/O INT. | 1 | |||
| GM1 ANTIBODY, ELISA | 28 | |||
| GOLDENROD (W12) IGE | 2 | |||
| GOOSE FEATHERS (E70) IGE | 5 | |||
| GQ1B ANTIBODY TEST | 1 | |||
| GRANZYME B W/O INTERP | 36 | |||
| GRANZYME B, IHC W/O INTER | 5 | |||
| GRAPE (F259) IGE | 5 | |||
| GRAPEFRUIT (F209) IGE | 1 | |||
| GREEN BEAN (F315) IGE | 5 | |||
| GREEN PEPPER (F263)** | 1 | |||
| GROSS CYSTIC DISEASE FLUD 15, IHC W/O INTERP | 5 | |||
| GROWTH HORMONE (GH) | 68 | |||
| GUIDELINE HEREDITARY CAN | 2 | |||
| GUINEA PIG EPITHELIA (E6) | 2 | |||
| GULF FLOUNDER (F147) IGE | 5 | |||
| H. INFLUENZAE TYPE B | 42 | |||
| HADDOCK,IGE | 5 | |||
| HALIBUT (RF303) IGE** | 5 | |||
| HALOPERIDOL | 28 | |||
| HANDLING CHARGE | 6066 | |||
| Handling Charges for Specimens sent to other labs (pass throughs) | 5 | |||
| HANTAVIRUS ABS(IGG,IGM) | 1 | |||
| HAZELNUT (F17) IGE | 42 | |||
| HBV DNA, QNT PCR W/REFLEX | 2 | |||
| HCG TOTAL QL | 5 | |||
| HCG, ALTERNATE METHOD | 5 | |||
| HCG,BETA,CSF | 5 | |||
| HCG,TOTAL,QN | 25 | |||
| HCV GENO 3 NS5A | 1 | |||
| HCV RNA GENOTYPE, LIPA(R) | 205 | |||
| HCV RNA W/RFL NS5A | 5 | |||
| HCV WITH REFLEXES | 5 | |||
| HCV, RNA, QUAN, PCR | 10 | |||
| HCV-INFECTED AUTOIMMUNE P | 5 | |||
| HDL CHOLESTEROL SUBCLASS | 1 | |||
| HDL-CHOLESTEROL | 17 | |||
| HDV RNA, QN | 5 | |||
| HE4, OVARIAN CANCER MONIT | 40 | |||
| HEAVY METALS 24HR UR W/CA | 6 | |||
| HEAVY METALS COMPR. PANEL | 8 | |||
| HEAVY METALS GROUP # 3 | 12 | |||
| HEAVY METALS GROUP # 4 | 26 | |||
| HEAVY METALS PANEL, 24HR | 17 | |||
| HEAVY METALS PANEL, BLOOD | 59 | |||
| HEAVY METALS PANEL, RANDM | 11 | |||
| HEAVY METALS PNL #27,24HR | 5 | |||
| HELICOBACTER PYLORI ANTIG | 203 | |||
| HELICOBACTER PYLORI, IHC | 1 | |||
| HELICOBACTER PYLORI, UREA | 23 | |||
| HELICOBACTER PYLORIIHC~2 | 5 | |||
| HEMATOLOGIC CULTURE | 6 | |||
| HEMOGLOBIN A1C | 65 | |||
| HEMOGLOBIN, FREE, SERUM | 2 | |||
| HEMOGLOBIN, PLASMA | 5 | |||
| HEMOGLOBINOPATHY EVAL | 182 | |||
| HEMOGLOBINOPATHY EVALUATI | 19 | |||
| HEMOSIDERIN STAIN, URINE | 4 | |||
| HEP A AB, TOTAL | 5 | |||
| HEP A IGM AB | 5 | |||
| HEP B CORE AB, (IGM) | 1 | |||
| HEP B CORE AB, TOTAL | 5 | |||
| HEP B CORE IGM AB | 5 | |||
| HEP B SURF AB QL | 5 | |||
| HEP B SURF AG W/CONF | 5 | |||
| HEP B SURFACE AB, QUANT | 535 | |||
| HEP B VIRUS DNA, QN PCR | 118 | |||
| HEP B VIRUS DRUG RESIST. | 4 | |||
| HEP C AB W/REFL HCV | 5 | |||
| HEP C VIRAL RNA NS5A DRUG | 4 | |||
| HEP C VIRAL RNA NS5B | 4 | |||
| HEP D VIRUS RNA | 1 | |||
| HEP D VIRUS(HDV)RNA, QU | 5 | |||
| HEP DELTA VIRUS AB | 20 | |||
| HEPARIN ANTI-XA | 5 | |||
| HEPARIN INDUCED ANTIBODY | 1 | |||
| HEPARIN INDUCED THROMBOCY | 5 | |||
| HEPATIC FUNC PNL | 18 | |||
| HEPATITIS A AB, TOTAL | 4 | |||
| HEPATITIS B CORE, IHC W/O INTERPRETATION | 5 | |||
| HEPATITIS B SURF AB QL | 5 | |||
| HEPATITIS B SURFACE AG | 1 | |||
| HEPATITIS B SURFACE ANTIGEN, IHC W/O INTERPRET | 5 | |||
| HEPATITIS B SURFACE W/O I | 5 | |||
| HEPATITIS B VIRUS DNA, | 5 | |||
| HEPATITIS BC W/O INTERP | 5 | |||
| HEPATITIS BE ANTIBODY | 26 | |||
| HEPATITIS BE ANTIGEN | 37 | |||
| HEPATITIS BE PANEL | 217 | |||
| HEPATITIS C VIRAL RNA | 4 | |||
| HEPATITIS D ANTIBODY, | 5 | |||
| HEPATITIS D VIRUS IGM AB | 8 | |||
| HEPATITIS E ANTIBODIES | 19 | |||
| HEPATITIS E ANTIBODY,IGM | 22 | |||
| HEPATITS E ANTIBODY (IGG) | 1 | |||
| HEPPAR-1 IHC W/INTERP | 5 | |||
| HEPPAR-1 IHC W/O INTERP | 1 | |||
| HER2 (HERCEPTEST(R)) IHC | 1 | |||
| HER2 (HERCEPTEST-TM) | 12 | |||
| HER2 (HERCEPTEST-TM), IHC PARAFFIN BLOCK W/O INTERP | 5 | |||
| HER2NEU W/O INTERP | 5 | |||
| HEREDITARY BREAST CANCER | 5 | |||
| Hereditary Cerebral Small Vessel Disease Panel | 5 | |||
| HEREDITARY COLORECTAL CAN | 1 | |||
| HEREDITARY HEMOCHROMATO- | 529 | |||
| HEREDITARY MDS/LEUKEMIA PANE | 5 | |||
| HEREDITARY MYELODYSPLASTIC | 5 | |||
| HEREDITARY PARAGANGLIOMA | 5 | |||
| HEREDITARY SENSORY &AUTONOMI | 5 | |||
| HEREDITARY THROMBOPHILIA PNL | 5 | |||
| HEROIN METAB,QN,U | 5 | |||
| HEROIN META-FREE (UNCONJU | 5 | |||
| HEROIN SCREEN, URINE | 5 | |||
| HERPES SIMPLEX VIRUS 1&2 | 65 | |||
| HERPES SIMPLEX VIRUS C | 5 | |||
| HERPES SIMPLEX VIRUS TYPE 1 AND 2, IHC W/O INTERP | 5 | |||
| HERPES VIRUS 6 DNA, QUAL | 5 | |||
| HERPES VIRUS 6 DNA, QUANT | 2 | |||
| HERPES VIRUS 7 DNA, QUANT | 1 | |||
| HERPES VIRUS 8 DNA,QUANT. | 5 | |||
| HERPESVIRUS 6 ABS(IG | 8 | |||
| HERPESVIRUS 6 IGG, IGM | 5 | |||
| HERPESVIRUS 7 IGG, IGM | 5 | |||
| HERPESVIRUS 8 IGG AB,IFA | 6 | |||
| HEXAGONAL PHASE CONFIRM | 98 | |||
| HGB & HCT | 5 | |||
| HHF35 MUSCLE ACTIN, IHC W/O INTERP | 5 | |||
| HHV-8 IHC W/O INTERP. | 2 | |||
| HICKORY/PECAN TREE(T22) | 5 | |||
| HIGH MOLECULAR WEIGHT | 5 | |||
| HIGH-GRADE LYMPHOMA | 8 | |||
| HISTAMINE RELEASE | 6 | |||
| HISTAMINE, 24HOUR URINE | 1 | |||
| HISTAMINE,PLASMA | 4 | |||
| HISTO SP STAIN GP I TC | 4 | |||
| HISTO SP STAIN GP I TC 2 | 4 | |||
| HISTO SP STAIN GP I TC 3 | 8 | |||
| HISTO SP STAIN GP I TC 4 | 5 | |||
| HISTO SP STAIN GP I TC 6 | 5 | |||
| HISTONE ANTIBODY | 144 | |||
| Histopathology Tissue/Biopsy | 5 | |||
| HISTOPLASMA AB,COMP FIXAT | 10 | |||
| HISTOPLASMA AB,IMMUNODIFF | 5 | |||
| HISTOPLASMA ANTIBODY, ID | 11 | |||
| HISTOPLASMA ANTIGEN | 60 | |||
| HISTOPLASMA CAPSULATUM | 6 | |||
| HISTOPLASMA GALACTOMANNAN | 16 | |||
| HIV 1 CORE TROPISM | 5 | |||
| HIV AG/AB 4TH GEN W/REFLX | 2 | |||
| HIV-1 CORECEPTOR TROPISM | 5 | |||
| HIV-1 GENOTYPE | 43 | |||
| HIV-1 GENOTYPE (RTI,PI,IN | 5 | |||
| HIV-1 INTEGRASE GENOTYPE | 16 | |||
| HIV-1 RESISTANCE | 5 | |||
| HIV-1 RNA, QT, REAL-TIME | 5 | |||
| HIV1/2 AG/AB,4 W/RFL | 1 | |||
| HIV-2 DNA/RNA QUALITATIVE | 41 | |||
| HLA AB ID CLASS II | 1 | |||
| HLA AB ID CLASS1 | 1 | |||
| HLA ANTIBODY DETECTION | 2 | |||
| HLA B*58:01 TYPING | 11 | |||
| HLA TYPING FOR CELIAC | 20 | |||
| HLA-A CLASS I DNA TYPING | 5 | |||
| HLA-A,B LOW RESULUTION | 5 | |||
| HLA-A,B LOW RESULUTION TY | 1 | |||
| HLA-A,B,C TRANSPLANTATION | 1 | |||
| HLA-A,B,C, LOW RESOLUTION | 5 | |||
| HLA-A29 DETERMINATION | 6 | |||
| HLA-B 5801 GENOTYPE | 5 | |||
| HLA-B*5701 TYPING | 6 | |||
| HLA-B*58:01 Typing HLA-B*58:01 | 5 | |||
| HLA-B27 ANTIGEN | 454 | |||
| HLA-B27 DETERMINATION | 1 | |||
| HLA-B51 DETERMINATION | 6 | |||
| HLA-DR/DQ LOW RESOLUTION | 5 | |||
| HLTV-1/-2 Ab Screen, CSF | 5 | |||
| HMB45 IHC W/O INTERP | 14 | |||
| HMGCR AB (IGG) | 56 | |||
| HOMOCYSTEINE | 5 | |||
| HOMOVANILLIC ACID (HVA) | 5 | |||
| HONEY BEE (I1) IGE | 16 | |||
| HOPS/FRUIT CONE IGE | 5 | |||
| HORSE DANDER (E3) IGE | 4 | |||
| HORSE HAIR IGE | 626 | |||
| HOUSE DUST (GREER)(H1) | 2 | |||
| HPV GENOTYPES 16, 18/45, | 4 | |||
| HPV HIGH/LOW ISH | 5 | |||
| HPV MRNA E6/E7, RECTAL | 5 | |||
| HPV MRNA E6/E7, RECTAL W/ | 6 | |||
| HPV MRNA E6/E7,RECTAL | 5 | |||
| HPV,LOWHIGH RISK RNA | 1 | |||
| HS CRP | 5 | |||
| HSV 1 IGG, TYPE-SPECIFIC | 5 | |||
| HSV 1&2 REAL TIME QN PCR | 5 | |||
| HSV 1,2 IGG,HERPESELECT | 421 | |||
| HSV 1/2 AB (IGM),W/REFLEX | 5 | |||
| HSV 1/2 IGG,TYPE SPECIFIC | 676 | |||
| HSV 2 IGG, TYPE SPECIFIC | 5 | |||
| HSV 2 IGM TITER | 5 | |||
| HSV TYPES 1 & 2 W/INTERP. | 4 | |||
| HSV TYPES 1 & 2 W/O INT. | 5 | |||
| HSV WESTERN BLOT | 5 | |||
| HSV, TYPE 1/2 DNA, QL | 5 | |||
| HSV1 IGM TITER | 5 | |||
| HSV2 IGG INHIBITION,ELISA | 91 | |||
| HTLV I/II DNA DETECTION | 4 | |||
| HTLV I/II,CONF ASSAY | 5 | |||
| HTLV-I/II ANTIBODY, W/ | 37 | |||
| HU AB TITER, SERUM | 5 | |||
| HU AB, WB | 4 | |||
| HU, YO, & RI AB W/REFLEX | 13 | |||
| HUMAN ANTI-GIARDIA LABLIA AB | 5 | |||
| HUMAN EHRLICHIOSIS DNA | 751 | |||
| HUMAN PAPILLOMAVIRUS H/L | 5 | |||
| HUMAN PLATELET ANTIGEN 1 | 5 | |||
| HUNTINGTON'S DISEASE MUTA | 1 | |||
| HYDROCEPHALUS PANEL | 5 | |||
| HYDROCODONE & MEETABOLITE | 5 | |||
| HYPER PNEUMO EVAL | 16 | |||
| HYPERPARATHYROIDISM PANEL | 5 | |||
| HYPERSENSITIVITY PNEUMO | 109 | |||
| HYPOGLYCEMIC AGENT SCREEN | 5 | |||
| HYPOGLYCEMIC PANEL, S/P | 1 | |||
| IA-2 ANTIBODY | 37 | |||
| IBUPROFEN, SERUM/PLASMA | 5 | |||
| IDH1 R132H BY IHC | 5 | |||
| IGA, IGG,IGM W/K &L QUANT | 644 | |||
| IGA, IHC W/O INTERP | 5 | |||
| IGD, SERUM | 14 | |||
| IGE AB(ANTI-IGE IGG) | 102 | |||
| IGF BINDING PROTEIN-3 | 2 | |||
| IGF I, LC/MS | 360 | |||
| IGF-2, LC/MS | 8 | |||
| IGG IHC W/INTERP | 5 | |||
| IGG IHC W/O INTERP | 5 | |||
| IGG SYNTHESIS RATE/INDEX, | 14 | |||
| IGG, CSF | 5 | |||
| IGG,IGA INDIRECT IMMUNOFL | 4 | |||
| IGG4, IHC W/INTERP | 5 | |||
| IGG4, IHC W/O INTERP | 5 | |||
| IGM, CSF | 5 | |||
| IGM, IHC W/O INTERPRETATI | 5 | |||
| IHC, 2 AB COCKT,TC 1 | 31 | |||
| IHC, 2 AB COCKT,TC 2 | 2 | |||
| IHC, 2 AB COCKT,TC 3 | 5 | |||
| IHC, 2 AB COCKT,TC 4 | 5 | |||
| IHC, 2 AB COCKT,TC 5 | 5 | |||
| IHC, 3 AB COCKT,TC 1 | 48 | |||
| IHC, 3 AB COCKT,TC 2 | 5 | |||
| IHC, 3 AB COCKT,TC 3 | 1 | |||
| IHC, 3 AB COCKT,TC 4 | 4 | |||
| IHC, 3 AB COCKT,TC 5 | 5 | |||
| IHC, 3 AB COCKT,TC 6 | 5 | |||
| IL-6 | 32 | |||
| IMCAP, BLUE MUSSEL (F37) | 5 | |||
| IMCAP, OYSTER (F290) | 5 | |||
| IMCAP, SCALLOPS (F338) | 5 | |||
| IMIPRAMINE | 5 | |||
| IMMUNE CELL FUNCTION | 7 | |||
| IMMUNE COMPLEX, C1Q | 14 | |||
| IMMUNO/AGGLUTINATI ID~2 | 5 | |||
| IMMUNOCYTO 1 AB,TC | 402 | |||
| IMMUNOCYTO 10 AB,TC | 5 | |||
| IMMUNOCYTO 11 AB,TC | 1 | |||
| IMMUNOCYTO 12 AB,TC | 1 | |||
| IMMUNOCYTO 13 AB,TC | 2 | |||
| IMMUNOCYTO 2 AB,TC | 91 | |||
| IMMUNOCYTO 3 AB,TC | 41 | |||
| IMMUNOCYTO 4 AB,TC | 37 | |||
| IMMUNOCYTO 5 AB,TC | 14 | |||
| IMMUNOCYTO 6 AB,TC | 14 | |||
| IMMUNOCYTO 7 AB,TC | 5 | |||
| IMMUNOCYTO 8 AB,TC | 4 | |||
| IMMUNOCYTO 9 AB,TC | 4 | |||
| IMMUNOCYTOCHEM 1 AB | 5 | |||
| IMMUNOFIXATION ELECT. | 58 | |||
| IMMUNOFIXATION PROFILE, 2 | 5 | |||
| IMMUNOFIXATION,URINE | 13 | |||
| IMMUNOGLOB. G SUBCLASSES4 | 71 | |||
| IMMUNOGLOBULIN E | 1 | |||
| IMMUNOGLOBULIN G SUBCLASS | 350 | |||
| IMMUNOGLOBULIN G, CSF | 5 | |||
| IMMUNOGLOBULIN M(IGM)CSF | 5 | |||
| IMMUNOHISTOCHEM W/INTERP | 5 | |||
| IMMUNOHISTOCHEM W/O INT | 5 | |||
| IMUNOHISCHEM W/O INTERP~2 | 5 | |||
| INFLAMMATORY BOWEL DISEAS | 26 | |||
| INFLIXIMAB | 5 | |||
| INFLIXIMAB LEVEL/ADA, IBD | 118 | |||
| INFLIXIMAB LEVEL/ADA,RHEU | 6 | |||
| INFLUENZA ANTIBODIES | 1 | |||
| INHERITED RETINAL DISORDERS | 5 | |||
| INHIBIN A | 1 | |||
| INHIBIN B | 6 | |||
| INHIBIN IHC W/O INTERP | 5 | |||
| INHIBIN, IHC W/INTERP | 5 | |||
| INI-1 W/OUT INTERP | 5 | |||
| INI-1, IHC W/O INTERP. | 1 | |||
| INSM1 IHC T-ONLY | 5 | |||
| INSULIN | 230 | |||
| INSULIN AUTOANTIBODIES | 84 | |||
| Insulinoma-Associated Protein 1 (INSM1) Immunostain | 5 | |||
| Intact Fibroblast Growth Factor 23 | 5 | |||
| INTERCELLULAR SUBSTANCE A | 5 | |||
| INTERFERON-BETAIGG,MAID ( | 5 | |||
| INTERLEUKIN-2 RECEPTOR | 44 | |||
| INTERLEUKIN-6,HIGHLY | 6 | |||
| INTRINSIC FACTOR ANTIBODI | 151 | |||
| IODINE, 24-HOUR URINE | 1 | |||
| IODINE, RANDOM URINE | 11 | |||
| IODINE, SERUM/PLASMA | 10 | |||
| IRON AND TOTAL IRON BINDI | 5 | |||
| IRON, TOTAL, & IBC | 4 | |||
| IRON, URINE | 5 | |||
| IRON-LIVER TISSUE | 5 | |||
| ISLET CELL ANTIBODY TITER | 2 | |||
| ISOHEMAGGLUTININ TITER | 5 | |||
| ITRACONAZOLE | 5 | |||
| ITRACONAZOLE, LC/MS/MS | 5 | |||
| IV-PATH,G&M,1SP,TC | 5 | |||
| JAK2 EXON 12 MUTATION ANA | 85 | |||
| JAK2 EXON 12, AND 13 | 5 | |||
| JAK2 V617F CASCADING RE | 30 | |||
| JAK2 V617F MUTATION ANAL | 119 | |||
| JAK2 V617F MUTATION, QT | 5 | |||
| JAK2 V617F,QL W/ RFL | 5 | |||
| JC POLYOMA VIRUS DNA, | 1 | |||
| JC VIRUS DNA ULTRASENSATV | 5 | |||
| JC VIRUS REAL-TIME QN PCR | 5 | |||
| JO-1 ANTIBODY | 144 | |||
| JOHNSON GRASS (G10) IGE | 1 | |||
| JUNE GRASS (G8) IGE | 2 | |||
| KAPPA IHC W/O INTERP | 32 | |||
| KAPPA ISH W/O INTERP | 6 | |||
| KAPPA/LAMBDA LIGHT CHAIN | 70 | |||
| KAPPA/LAMBDA LIGHT CHAIN ISH WITH INTERP | 5 | |||
| KAPPA/LAMBDA LIGHT CHAIN, ISH W/O INTERP | 5 | |||
| KAPPA/LAMBDA LIGHT CHAINS | 11 | |||
| KAPPA/LAMBDA, FREE, SERUM | 5 | |||
| KETAMINE & METAB CONF,S/P | 5 | |||
| KETAMINE AND METABOLITE | 5 | |||
| KI-67, W/O INTERP | 17 | |||
| KIT Asp816 Val Mutation Anal | 5 | |||
| KIT D816 | 8 | |||
| KITVS | 5 | |||
| KIWI FRUIT (F84) IGE | 2 | |||
| KRAS MUTATION ANALYSIS | 5 | |||
| L. PNEUMOPHILA ANTIGEN | 1 | |||
| L. PNEUMOPHILA CULTURE | 10 | |||
| LACOSAMIDE,LC/MS/MS | 42 | |||
| LACTATE DEHYDROGENASE | 5 | |||
| LACTATE DEHYDROGENASE ISO | 5 | |||
| LACTIC ACID, CSF | 1 | |||
| LACTOFERRIN, STOOL | 1 | |||
| LAMB (F88) IGE | 5 | |||
| LAMBDA, IHC W/O INTERP | 11 | |||
| LAMBERT-EATON SYNDROME | 2 | |||
| LAMOTRIGINE | 485 | |||
| LATEX (K82) IGE | 6 | |||
| LAXATIVES PANEL | 5 | |||
| LD, CSF | 10 | |||
| LD, PERICARDIAL FLUID | 8 | |||
| LD, SYNOVIAL FLUID | 5 | |||
| LDH ISOENZYME ELECTROPHOR | 6 | |||
| LDH, TOTAL | 1 | |||
| LEAD, 24 HR URINE | 11 | |||
| LEAD, BLOOD | 341 | |||
| LEAD, RANDOM URINE | 5 | |||
| LEAD, URINE, 24HR (W/O | 5 | |||
| LEF 1 W/O INTERP | 5 | |||
| LEFLUNOMIDE METABOLITE | 5 | |||
| LEGIONELLA ANTIBODY PANEL | 5 | |||
| LEGIONELLA ANTIGEN,EIA UR | 14 | |||
| LEGIONELLA DNA, QUAL RT | 4 | |||
| LEGIONELLA PNEUM AB IGG | 1 | |||
| LEGIONELLA PNEUM AB IGM | 1 | |||
| LEISHMANIA ANTIBODY (IGG) | 5 | |||
| LEMON (F208) IGE | 4 | |||
| LEMS AUTOANTIBODY TEST | 10 | |||
| LEPTIN | 2 | |||
| LEPTOSPIRA AB, IGM | 7 | |||
| LEPTOSPIRA DNA, QUALITATI | 8 | |||
| LETTUCE (F215) IGE | 1 | |||
| LEUK&LYMP EVAL,14 MARKR | 5 | |||
| LEUK&LYMP EVAL,22 MARKR | 7 | |||
| LEUK&LYMP EVAL,23 MARKR | 4 | |||
| LEUK&LYMP EVAL,24 MARKR | 2 | |||
| LEUK&LYMP EVAL,25 MARKR | 1 | |||
| LEUKEMIA/LYMPHOMA EVAL | 5 | |||
| LEUKOTRIENE E4, U | 5 | |||
| LEUKOVANTAGE(R), MYELOID | 25 | |||
| LEUKOVANTAGE(TM),(MPN) | 7 | |||
| LEVEL I Gross Only | 5 | |||
| LEVEL II SURGICAL PATH base code 0022020 | 5 | |||
| LEVEL III SURGICAL PATH base code 0022040 | 5 | |||
| LEVEL IV SURGICAL PATH base code 0022050 | 5 | |||
| LEVEL V SURGICAL PATH base code 0022070 | 5 | |||
| LEVETIRACETAM | 5 | |||
| LEVETIRACETAM IA | 460 | |||
| LGI1 ANTIBODY TEST | 5 | |||
| LGI1-IGG CBA, S | 5 | |||
| LH | 5 | |||
| LH, SERUM | 1 | |||
| LIDOCAINE | 1 | |||
| LIPASE, JP DRAINAGE | 1 | |||
| LIPASE, PANCREATIC FLUID | 1 | |||
| LIPASE, PERITONEAL FLUID | 26 | |||
| LIPASE, PLEURAL FLUID | 41 | |||
| LIPASE, SERUM | 5 | |||
| LIPASE, URINE | 5 | |||
| LIPID ANALYSIS, BF | 2 | |||
| LIPID ANALYSIS,BODY FLUID | 5 | |||
| LIPOPROTEIN (A) | 2 | |||
| LIPOPROTEIN A (LP(A)) | 704 | |||
| LIPOPROTEIN ELEC | 1 | |||
| LIPOPROTEIN ELECTROP | 46 | |||
| LIPOPROTEIN FRAC,NMR W/LI | 5 | |||
| LISDEXAMFETAMINE AS METABOLI | 5 | |||
| LISTERIA ANTIBODY,CF CSF | 5 | |||
| LITHIUM | 5 | |||
| LIVER CYTOSOL (LC-1) AUTO | 5 | |||
| LIVER FIBROSIS, FIBROTEST | 19 | |||
| LIVER KIDNEY MICROSOME | 173 | |||
| LMWH - SEROTONIN (14C) | 1 | |||
| LOBSTER (F80) IGE | 48 | |||
| LORAZEPAM (ATIVAN) | 5 | |||
| LORAZEPAM, URINE | 5 | |||
| LOXAPINE,SERUM/PLASMA | 5 | |||
| LRP4 AUTOANTIBODY | 67 | |||
| LSD PRESUMPTIVE SCREEN | 5 | |||
| LSD, QUANTITATION URINE | 5 | |||
| LUNG CA(NSCLC), ALK, FISH | 5 | |||
| LUNG CA(NSCLC), ROS1, FIS | 5 | |||
| LUNG CANCER MUTATION PNL | 5 | |||
| LUNG CANCER(NSCLC) ROS1 (6Q22) REARRANGEMENT, FISH | 5 | |||
| LUNG CANCER(NSCLC), ALK 2P23 REARRANGEMENT, FISH | 5 | |||
| LUPUS ANTICOAGULANT EVAL | 349 | |||
| LUPUS ERYTHEMATOSIS PRO | 5 | |||
| LURASIDONE, SERUM/PLASMA | 5 | |||
| LYME AB W/REFL IA | 5 | |||
| LYME DISEASE (BORRELIA | 5 | |||
| LYME DISEASE AB (IGG)IBL | 5 | |||
| LYME DISEASE AB INDEX CNS | 8 | |||
| LYME DISEASE AB W/RFLX TO | 25 | |||
| LYME DISEASE ANTIBODIES | 4 | |||
| LYME DISEASE DNA TICK | 5 | |||
| LYME DISEASE DNA, REAL-TI | 5 | |||
| LYME G/M,WB (CSF) | 16 | |||
| LYMPHOCYTE SUBSET PANEL 1 | 4 | |||
| LYMPHOCYTE SUBSET PANEL 2 | 1 | |||
| LYMPHOGRANULOMA VENEREUM | 1 | |||
| LYMPHOID ENHANCING FACTOR | 5 | |||
| LYNCH SYND MLH1 SEQ & DEL | 5 | |||
| LYNCH SYND TUMOR PNL,IHC | 2 | |||
| LYNCH SYND, PMS2 SEQ/DEL/ | 5 | |||
| LYNCH SYNDROME PANEL | 1 | |||
| LYNCH SYNDROME TUMOR PANEL, IHC W/O INTERP. | 5 | |||
| LYSERGIC ACID DIETHYLAMIDE | 5 | |||
| LYSOZYME W/O INTERP | 5 | |||
| M. PNEUMONIAE AB (IGM) | 19 | |||
| M.GENITALIUM, TMA | 5 | |||
| MA903 CYTOK 34BE12 W/O IN | 17 | |||
| MACADAMIA NUT (RF345)IGE | 41 | |||
| MACHADO-JOSEPH DISEASE | 5 | |||
| MAG AB (IGM), EIA | 8 | |||
| MAG AB (IGM), WB | 1 | |||
| MAGNESIUM | 1 | |||
| MAGNESIUM, MG/24H, NO CR | 55 | |||
| MAGNESIUM, RBC | 4 | |||
| MAGNESIUM,RANDOM UR W/CRE | 46 | |||
| MAGNESIUM,STOOL | 5 | |||
| MAG-SGPG AB (IGM), EIA | 8 | |||
| MAI PROBE | 5 | |||
| MAIL OUT TEST | 874 | |||
| MALARIA PCR | 5 | |||
| MALARIA/BABESIA/OTHER | 352 | |||
| MALIGNANT HYPERTHERMIA SUSC | 5 | |||
| MALT (F90) IGE | 5 | |||
| MAMMAGLOBIN, IHC W/O INT. | 5 | |||
| MANGANESE | 8 | |||
| MANGANESE,BLOOD | 4 | |||
| MANGO (F91) IGE | 5 | |||
| MANNAN BINDING LECTIN(C4B | 5 | |||
| MANTLE CELL LYMPHOMA | 6 | |||
| MAPLE (BOX ELDER)(T1) | 5 | |||
| MARIJAUNA CONF GCMS, URIN | 5 | |||
| MARIJUANA CONF GCMS, SERU | 7 | |||
| MART-1 W/O INTERP | 2 | |||
| MAST CELL TRYPTASE, W/O INTERP | 5 | |||
| MDMA W CONF | 5 | |||
| MDMA/MDA,QN,U | 5 | |||
| ME METAB QN U | 5 | |||
| MEASLES AB (IGG,IGM) | 4 | |||
| MEASLES ANTIBODY (IGG) | 5 | |||
| MEASLES ANTIBODY (IGM) | 7 | |||
| MELAN-1 W/O INTERP | 5 | |||
| MELAN-A, IHC W/O INTERPRE | 5 | |||
| MELANOMA ANTIGEN RECOG BY T CELLS, IHC W/O INTERP | 5 | |||
| MELANOMA, BRAF V600 MUTATION, COBAS | 5 | |||
| MELAS MTDNA MUTATION PROF | 5 | |||
| MELON (F87) IGE | 1 | |||
| MEN1 SEQ, DEL/DUP | 5 | |||
| MENINGOENCEPHALITIS PANEL | 5 | |||
| MEPERIDINE,QN,U | 5 | |||
| MERCURY | 61 | |||
| MERCURY, 24 HOUR URI | 4 | |||
| MERCURY, 24 HOUR URINE | 4 | |||
| MERCURY, SERUM/PLASMA | 8 | |||
| MERKEL CC IHC, TECH ONLY | 5 | |||
| METANEPHRINES, FRACT. | 166 | |||
| METANEPHRINES, LC/MS/MS | 377 | |||
| METANEPHRINES,FRACTIONATE | 26 | |||
| METFORMIN | 2 | |||
| METHADONE, QUANT. GCMS | 23 | |||
| METHAMP ISOMERS,U | 5 | |||
| METHAQUALONE PRESUMPTIVE | 5 | |||
| METHAQUALONE, UR | 5 | |||
| METHEMOGLOBIN | 2 | |||
| METHOTREXATE | 5 | |||
| METHYL ALCOHOL, BL OR SER | 5 | |||
| METHYLENETETRAHYDROFOLATE | 19 | |||
| METHYLMALONIC ACID | 1266 | |||
| METHYLMALONIC ACID U | 4 | |||
| METHYLPHENIDATE METAB., Q | 5 | |||
| METOPROLOL | 5 | |||
| MEXILETINE, S/P | 5 | |||
| MI-2 AUTOANTIBODIES | 5 | |||
| MIC (MICROSCAN) | 17 | |||
| MIC (MICROSCAN)~2 | 5 | |||
| MICAFUNGIN | 5 | |||
| MICROALBUMIN RAND UR | 1 | |||
| MICROSATELLITE INSTABILIT | 7 | |||
| MICROSPORIDIA EXAM | 1 | |||
| MILK COMPONENT PANEL | 5 | |||
| MILLER FISHER SYN., AB PA | 5 | |||
| MIMIMUM INHIBITORY CONC. | 10 | |||
| MINIMUM INHIBITORY CONCEN | 2 | |||
| MIRTAZAPINE | 5 | |||
| MISC CODE | 25 | |||
| MISC-CHANTILLY | 1 | |||
| MIT-INDUCED LYMPH PROLIF | 8 | |||
| MITOCHONDRIAL AB TITER | 4 | |||
| MITOCHONDRIAL ANTIBODY SC | 187 | |||
| MITRAGY QN U | 5 | |||
| MITRAGYNINE (QUALITATIVE) | 5 | |||
| Mitragynine and Metabolite (Qualitative), Urine | 5 | |||
| MITROCHONDRIAL M2 ANTIBO | 370 | |||
| MLH1 METHYLATION | 2 | |||
| MLH1, IHC W/O INTERP | 1 | |||
| MLH1, IHC W/O INTERP | 5 | |||
| MLH1, IHC WITH INTERP. | 5 | |||
| MMP-P | 5 | |||
| MMR (IGG) PANEL(MEASLES | 1 | |||
| MNG NGS445 COMP NEUROPATHIES | 5 | |||
| MOC-31 W/INTERP | 5 | |||
| MOC-31 W/O INTERP | 5 | |||
| MODAFINIL/ARMODAFINIL, S/P | 5 | |||
| MODIFIED ACID-FAST STAIN | 1 | |||
| MOG AB TITER, SERUM | 5 | |||
| MOG AB W/RFL TITER,C | 4 | |||
| MOG AB W/RFL TITER,S | 17 | |||
| MOG AB, CBA, SERUM | 8 | |||
| MOG AB, TITER, SERUM | 1 | |||
| MOLD ALLERGY PANEL #7 | 7 | |||
| MOLD ID | 131 | |||
| MOLD PANEL #4 | 644 | |||
| MOLD SUSCEPTIBILITY, 5 DR | 1 | |||
| MONKEYPOX VIRUS PCR | 5 | |||
| MONOGENIC OBESITY PANEL | 5 | |||
| MORPHINE FREE (UNCO | 5 | |||
| MOSQUITO (I71) IGE | 5 | |||
| MOUSE (E88) IGE | 634 | |||
| MOUSE EPITHELIA(E71)IGE | 1 | |||
| MOUSE URINE PROTEINS | 1 | |||
| MPHENIDATE M,QN,U | 5 | |||
| MPL MUT ANALYSIS (QUAL) | 40 | |||
| MPL W515 & MPL S505 MUTAT | 5 | |||
| MPN CORE DX PANEL | 32 | |||
| MPO IHC W/O INTERP | 1 | |||
| MPS | 5 | |||
| MPZ DNA SEQUENCING TEST | 5 | |||
| MSA AB PANEL | 83 | |||
| MSH2, IHC W/O INTERP | 1 | |||
| MSH2, IHC WITH INTERP. | 5 | |||
| MSH6, IHC W/O INTERP | 1 | |||
| MSH6, IHC WITH INTERP | 5 | |||
| MTB & RIFAM RESIS NON-SPU | 5 | |||
| MTB COMPLEX DIRECT DETECT | 5 | |||
| MTB/RIF, PCR | 5 | |||
| MUC2 WITHOUT INTERP | 5 | |||
| Mucin 2 IHC, Tech Only | 5 | |||
| MULTIPLE SCLEROSIS EVALUA | 11 | |||
| MULTIPLE SCLEROSIS PANEL2 | 2 | |||
| MUM1, IHC W/O INTERP | 1 | |||
| MUMPS AB IGG, EIA | 5 | |||
| MUMPS IGM AB, EIA | 1 | |||
| Mumps Virus AB(IgM) Mumps Virus AB (IgM) | 5 | |||
| MUMPS VIRUS RNA, QUAL | 5 | |||
| MURAMIDASE, SERUM | 38 | |||
| MUSCLE FIBERS, FECAL | 11 | |||
| MUSCULAR DYSTROPHY PANEL | 5 | |||
| MUSHROOM (RF212) IGE** | 5 | |||
| MUSK ANTIBODY TEST | 107 | |||
| MUSK QUANT. TITERS AB | 5 | |||
| MUSK+LRP4 AB PANEL | 5 | |||
| MUSTARD (F89) IGE | 5 | |||
| MVISTA(TM)BLASTOMYCES EIA | 18 | |||
| MYASTHENIA GRAVIS PANEL 2 | 25 | |||
| MYASTHENIA GRAVIS PNL #3 | 29 | |||
| MYCOBACTERIA, CULTURE, | 5 | |||
| MYCOPHENOLIC ACID | 10 | |||
| MYCOPLASMA HOMINIS/UREAPL | 8 | |||
| MYCOPLASMA PNEUMONIA AB | 16 | |||
| MYCOPLASMA PNEUMONIAE | 1 | |||
| MYCOPLASMA PNEUMONIAE AB | 16 | |||
| MYD88, MUTATION ANALYSIS | 8 | |||
| MYELIN AB, IFA,TITER | 1 | |||
| MYELIN ASSOCIATED GLYCO | 2 | |||
| MYELIN ASSOCIATED GLYCOPR | 73 | |||
| MYELIN BASIC PROTEIN | 1 | |||
| MYELIN-ASSOCIATED GLYCO- | 4 | |||
| MYELOPEROX. IHC W/INTERP. | 5 | |||
| MYELOPEROXIDASE ANTIBODY | 122 | |||
| MYELOPEROXIDASE, IHC W/O INTERP | 5 | |||
| MYO D1, IHC W/O INTERPRET | 5 | |||
| MYOCARDIAL ANTIBODIES | 5 | |||
| MYOGENIN, IHC W/O INTERPR | 5 | |||
| MYOGLOBIN, SERUM | 25 | |||
| MYOGLOBIN, URINE | 5 | |||
| MYOGLOBULIN, URINE | 10 | |||
| MYOSIN-SMOOTH W/O INTERP | 1 | |||
| MYOSITIS ASSESSR PLUS JO- | 5 | |||
| MYOSITIS ASSESSR(TM) | 5 | |||
| MYOTONIC DYSTROPHY TYPE 2 | 5 | |||
| N METHYLHISTAMINE, 24, U | 5 | |||
| NALOXONE, QUANT URINE | 5 | |||
| NALTREXONE,QN,U | 5 | |||
| NAPSIN A, IHC W/O INTERP. | 5 | |||
| NASH FIBROSURE | 5 | |||
| NECTARINE IGE | 4 | |||
| NEISSERIA GONO CULTURE | 1 | |||
| NEISSERIA MENIGIIDIS IGG | 5 | |||
| NEOCEREBELLAR DEGENERATIO | 2 | |||
| NEOCOMPLETE PARANEOPLASTI | 5 | |||
| NEOENCEPHALITIS PARANEOPL | 5 | |||
| NEURO AB, LINE BLOT | 1 | |||
| NEURO AB,LINE BL W/R | 4 | |||
| NEUROFASCIN | 5 | |||
| NEUROFILAMENT PROTEIN, IHC W/O INTERPRETATION | 5 | |||
| NEUROKININ A (SUBSTANCE K | 5 | |||
| NEUROMUSCULAR AB PANEL | 5 | |||
| NEUROMYELITIS OPTICA IGG | 5 | |||
| NEUROMYELITIS OPTICA(NMO) | 11 | |||
| NEURON SPECIFIC ENOLASE | 10 | |||
| NEURONAL NUCLEAR (HU) AB | 24 | |||
| NEURONAL NUCLEAR AB (HU) | 5 | |||
| NEURONAL NUCLEAR AB (YO), | 5 | |||
| NEURONAL NUCLEAR AB, RI, | 5 | |||
| NEURON-SPECIFIC ENOLASE | 5 | |||
| NEURON-SPECIFIC ENOLASE IHC W/O INTERPRETATION | 5 | |||
| NEUROPATHY/NEURONOPATHY PANL | 5 | |||
| NEUTROPHIL ANTIBODY, FC | 1 | |||
| NEUTROPHIL FUNCTION, | 1 | |||
| NEXTGEN SEQUENCING PANEL | 5 | |||
| NFP IHC W/INTERP | 5 | |||
| NFP IHC W/O INTERP | 5 | |||
| NGS330 COMPREHENSIVE | 5 | |||
| NGS405 | 5 | |||
| NICKEL, 24HR URINE W/O CR | 1 | |||
| NICKEL, SERUM/PLASMA | 5 | |||
| NICOTINE & COTININE, URIN | 148 | |||
| NICOTINE & MTB, S/P | 61 | |||
| NICOTINE & MTB,URINE | 10 | |||
| NIJMEGEN ASSAY | 1 | |||
| NK CELLS, FUNCTIONAL | 5 | |||
| NKX3.1, IHC W/O INT | 5 | |||
| NMDA RECEPTOR AB | 4 | |||
| NMDAR1 AB,CBA IFA,TITER | 1 | |||
| NMO SPEC EVAL RFL, S | 8 | |||
| NMO/AQP4 FAC S TITER,S | 5 | |||
| NMO/AQP4-IGG, FACS, CSF | 2 | |||
| NMR LIPO PROFILE | 5 | |||
| NMR LIPOPROFILE+LIPIDS+GRAPH | 5 | |||
| NMS 0921SP CADMIUM S/P | 5 | |||
| NMS 4120SP ROPIVICAINEn | 5 | |||
| NOROVIRUS RNA, RT-PCR | 11 | |||
| NORTHEAST REGIONAL MIXED | 422 | |||
| NORTRIPTYLINE | 8 | |||
| NORWALK-LIKE VIRUS (NLV), | 5 | |||
| NOTCH3 SEQ TEST | 5 | |||
| NPM (EXON 12) MUT ANALYSIS CELL-BASED | 5 | |||
| NPS QN,U | 5 | |||
| NRAS MUTATION ANALYSIS | 5 | |||
| NSE IHC W/O INTERP | 1 | |||
| N-TELOPEPTIDE (NTX), 24 H | 1 | |||
| N-TELOPEPTIDE SERUM | 5 | |||
| NUT1 | 5 | |||
| OAK (T7) IGE | 2 | |||
| OAT (F7) IGE | 4 | |||
| OLANZAPINE (ZYPREXA R ) | 79 | |||
| OLIGOCLONAL BANDS (IGG), | 31 | |||
| OLIGOCLONAL BANDS,CSF | 5 | |||
| OMEGA FATTY ACIDS | 11 | |||
| OMEGACHECK(TM) | 4 | |||
| ONCOVANTAGE | 5 | |||
| ONION (F48) IGE | 4 | |||
| OPI EXPANDED QN U | 5 | |||
| OPI/OXY QN | 5 | |||
| OPIATES - TOTAL | 4 | |||
| OPIATES QN U | 5 | |||
| OPIATES, CONFIRM, BY GCMS | 5 | |||
| OPIATES-TOTAL(CONJUGATED/ | 5 | |||
| OPMD REPEAT EXPANSION TEST | 5 | |||
| OPMD TC300 (ATHENA) | 5 | |||
| ORANGE (F33) IGE | 5 | |||
| OREGANO (RF283) IGE** | 5 | |||
| ORG ACID COMP QUANT U | 1 | |||
| ORG ID 1 | 1 | |||
| ORGANISM SUBM. NOT FUNGUS | 2 | |||
| OSMOLALITY, FECES | 29 | |||
| OSMOLALITY, SERUM | 6 | |||
| OSMOTIC GAP, FECES | 5 | |||
| OSTEOCALCIN,N-MID | 1 | |||
| OVA & PARASITES, STOOL | 462 | |||
| OVA AND PARASITES | 5 | |||
| OXALATE (OXALIC ACID) | 42 | |||
| OXALATE, SERUM/PLASMA | 2 | |||
| OXALIC ACID,24-HOUR URINE | 25 | |||
| OXCARBAZEPINE METABOLITE | 86 | |||
| OXIDIZED LDL | 5 | |||
| OXYCODONE AND METABOLITE | 7 | |||
| OXYCODONE QN U | 5 | |||
| OXYCODONE-FREE | 5 | |||
| OYSTER (F290) IGE | 46 | |||
| P16 IHC W/INTERP | 5 | |||
| P16, IHC W/O INTERP | 11 | |||
| P190 BCR-ABL1 | 134 | |||
| P210 BCR-ABL1 | 330 | |||
| P40, IHC W/O INTERP | 1 | |||
| P504S IHC W/O INTERP | 5 | |||
| P53 IHC W/INTERP | 5 | |||
| P53 MUTATION ANALYSIS, | 12 | |||
| P53, IHC W/O INTERPRETATI | 1 | |||
| P63, IHC W/O INTERP | 5 | |||
| PAIN MGMT, CYP450 | 5 | |||
| PAIN MGMT, METHYL- | 5 | |||
| PAIN MGT GABAPENTIN QUANT | 5 | |||
| PAIN, CYP450 3A4 GENO, QU | 5 | |||
| PAIN, CYP450 3A4/3A5 GENO | 5 | |||
| PAIN, CYP450 3A5 GENO, QU | 5 | |||
| PALIPERIDONE | 34 | |||
| P-ANCA TITER | 22 | |||
| PANCR. POLYPEPTIDE | 2 | |||
| PANCREASTATIN | 5 | |||
| PANCREATIC ELASTASE-1 | 353 | |||
| PANCREATIC POLYPEPTIDE | 5 | |||
| PAPER WASP (I4) IGE | 16 | |||
| PAPRIKA (F218) IGE | 5 | |||
| PARALDEHYDE & METABOLITE | 5 | |||
| PARANEO EVAL, W/REFL | 53 | |||
| PARANEOPLASTIC AB EVAL | 12 | |||
| PARANEOPLASTIC AB, EXPAND | 35 | |||
| Paraneoplastic Autoantibody Evaluation | 5 | |||
| PARANEOPLASTIC WB | 5 | |||
| PARASITE IDENTIFICATION | 2 | |||
| PARIETAL CELL AB, ELISA | 61 | |||
| PARKINSON DISEASE/PARKINSONI | 5 | |||
| PARMESAN CHEESE,IGE | 5 | |||
| PAROXETINE, URINE | 5 | |||
| PARROT/PARAKEET FEATH(E78 | 5 | |||
| PARTIAL THROMBOPLASTIN TI | 5 | |||
| PARVOVIRUS B19 AB IGG IGM | 41 | |||
| PARVOVIRUS B19 DNA, QUAL | 5 | |||
| PARVOVIRUS B19 DNA,QN PCR | 19 | |||
| PARVOVIRUS B19 IGM | 1 | |||
| PARVOVIRUS B19, AB IGG | 2 | |||
| PARVOVIRUS B19, IHC W/O | 5 | |||
| PASSION FRUIT(RF294)** | 1 | |||
| PAX2, IHC W/O INTERP | 1 | |||
| PAX-5, IHC W/O INTERP. | 5 | |||
| PAX8, IHC WITH INTERP. | 5 | |||
| PAX8, IHC WITHOUT INTERP. | 1 | |||
| PCB PANEL, CONGENERS | 5 | |||
| PCP QN U | 5 | |||
| PD-1, IHC W/O INTERP | 1 |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .